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 ABSTRACT 
This dissertation describes the integration of a microfluidic flow cell array (MFCA) 
with surface plasmon resonance microscopy (SPRM) and the application of MFCA-
SPRM system for microarray analysis of biomolecule interactions.  
The design and construction of a SPR microscope with a sensing area that is 
compatible with the fluidics footprint of the MFCA is described first. Antibody-antibody 
interactions are used as the model system to demonstrate the capability of the integrated 
MFCA-SPRM for in situ microarray fabrication and analysis. Impacts of 
physicochemical parameters, such as reactant concentrations, reaction constants and the 
flow rate, on the performance of the MFCA-SPRM are investigated by experiments and 
modeling. Optimized experimental conditions will support the future application of the 
MFCA-SPRM. Statistical analysis of microarray data (24 micro spots) shows that the 
spot-to-spot coefficient of variation is within 15%. Major sources of signal variance are 
from the deviation of light incident angle, heterogeneous sensing surface and the mass 
transport. 
     Next, a proof-of-principle experiment demonstrates the potential of the MFCA-SPRM 
system for immunogenicity assays of Daclizumab to analyze anti-drug antibodies (ADA) 
from serum samples. Daclizumab is a monoclonal antibody drug for treatment of multiple 
sclerosis patients. Biotinylated-Daclizumab immobilized on a streptavidin monolayer is 
used to assess the presence of ADA in serum samples of three patients with multiple   
iv 
 
sclerosis. The result shows that the sample from a patient without the treatment of 
Daclizumab generates the highest SPR signal. In the future, more samples are required to 
generate statistically significant data to evaluate the immunogenicity of Daclizumab.  
Matrix-assisted laser desorption/ionization mass spectrometer (MALDI MS) is an ideal 
tool to be combined with SPR for protein analysis. An antibody microarray created by 
MFCA and coupled to MS is utilized to demonstrate the potential of microarray analysis 
with SPR-MS.  
Finally, we apply MFCA-SPRM system for characterization of in situ immobilized 
vesicles on solid surfaces. Hydrophilicity of surface, vesicle size and composition are 
investigated as factors that affect the structure of vesicles adsorbed on surfaces. A model 
for the calculation of the surface area of the bilayer is proposed to correlate the SPR 
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Surface plasmons (SPs) are electromagnetic waves propagating along a dielectric and 
metal interface. They are generated by the interaction between the free electrons of the 
metal and an electromagnetic field.
1
 The phenomenon of SPs was first observed by Wood 
in the beginning of the 20th century by reporting anomalous diffraction of light with 
metallic gratings.
2
 In 1957, the concept of a plasmon was introduced by Ritchie to 
theoretically explain the energy loss experienced by fast electrons traveling through thin 
metal foils.
3
 In the late 1960s, optical excitation of SPs based on attenuated total 
reflection (ATR) was demonstrated by Otto and Kretschmann.
1
 Recently, with the 
development of nanotechnology, manipulating optical properties of SPs on the nanoscale 




Based on the excitation mode of SPs, the study of SPs can be divided into localized 
surface plasmons (LSPs) and surface plasmon polaritons (SPPs).
7
 LSPs are charge 
density oscillations confined to metallic nanoparticles or nanostructures, resulting in 
strong light scattering and absorption as well as enhanced local electromagnetic field.
8
 







 The loss of light due to absorption and scattering is 
characterized by peaks in SPs extinction spectra.  Properties of the extinction peaks, such 
as frequency and intensity, depend on the nanostructure materials, size, shape, 
distribution and surrounding environment, which promotes the development of LSPs-
based waveguide and sensors.
11
 However, we will focus on excitation of SPPs at a metal 
film-dielectric interface with light in an ATR configuration for biosensing. The 
dependence of the properties of SPPs on the dielectric constant of the local environment 
is the fundamental basis for SPR sensing.
12-14
 
SPPs are surface-bound electromagnetic waves propagating at a metal-dielectric 
planar interface as shown in Figure 1.1a.
5
 They are transverse waves with the electric 
field perpendicular to the traveling direction in the positive x-direction shown in the 
Figure 1.1a. Figure 1.1b illustrates the electric field being enhanced in the surface and 
decaying exponentially into the metal and dielectric medium. By solving Maxwell’s 
equations and using the physical parameters of a gold-water interface with an excitation 
wavelength of 630 nm, the decay lengths of SPPs in water and gold are 162 and 29 nm, 
respectively.
2
 The propagation length of SPPs in the x-y plane is 3 µm. The decay and 
propagation lengths of SPPs determine the spatial detection limit and resolution of SPR 
microscope because SPR sensing depends on the excitation of SPPs. Figure 1.1c 
compares the dispersion curves of SPPs and a free space photon to excite SPPs. It shows 
that there is always a momentum mismatch between SPPs and the light photon for the 
same frequency. Some strategies are needed to overcome the momentum mismatch. 
Grating and prism coupling are two major configurations used in the setup of SPR 
microscopes.
2





Surface Plasmon Resonance Sensing 
Surface plasmon resonance (SPR) sensing has been widely used in biomedical, 
pharmaceutical, food and environmental research to study biomolecular interactions at 
solid-liquid interfaces.
2, 15
 The principle of SPR sensing is characterized by the dispersion 
relation of SPPs at a planar dielectric-metal interface. Under appropriate boundary 
conditions shown in Figure 1.2, solving Maxwell’s equation yields the dispersion relation 
of SPPs. The SPPs wave vector ksp can be expressed as:  




    
     
                                                                                                                            
where ω is the angular frequency of incident light, c is the speed of light in vacuum, and 
εd and εm  are the dielectric constants of the dielectric and metal, respectively. As 
discussed above, the incidence light wave vector of k = w/c can’t match that of SPPs. 
One strategy to overcome the mismatch is to utilize the evanescent wave generated 
through ATR with prism coupling (wave vector shown in Equation 1.2) to match the 
momentum required by SPPs. A scheme of the experimental arrangement is shown in 
Figure 1.2. The wave vector of the evanescent wave kEW is: 
     
 
 
                                                                                                                         
where εp is the dielectric constant of the prism and θ is the light incident angle. With high 
refractive index of the prism and proper angle of incident light, if the metal film is 
brought within the range of the evanescent wave, SPPs can be excited when         . 





energy conservation, the energy of incident light is equal to the energy of light absorbed 
by SPPs and reflected from the interface. As a result, the reflected light intensity drops 
and the dropped intensity depends on the coupling conditions. When proteins or other 
biomolecules bind to the metal surface, the dielectric constant εd will be  changed, which 
will also cause following changes of the wave vector of SPPs, SPR coupling conditions 
and light intensity of reflected light as expressed in Equations 1.1 and 1.2. Therefore, the 
change of dielectric constant can be indirectly detected via measuring the reflected light 
properties. Since the refractive index (n =     ) is proportional to the dielectric constant 
εd, it is also possible to measure the change of refractive index caused by the adsorption 
of biomolecules in the same manner.  
Depending on the detection mode, a prism-based SPR system can be set up for either 
SPR spectroscopy or SPR microscopy (also called SPR imaging). SPR spectroscopy 
typically relies on measuring a SPR curve with either a spectrophotometer or a position-
sensitive detector, which is a plot of the reflected light intensity versus the light 
wavelength or incident angle. SPR microscopy uses a CCD camera as a detector to 
monitor the reflected light intensity from the entire sensing region to form a digital image. 
The intensity values for selected pixels in the generated gray-scale images can be 
correlated with the amount of material adsorbed on the sensor surface.
16, 17
 The 
microscopy format provides spatially-resolved measurements which offer opportunities 
for multiple, simultaneous control experiments and parallel processing of larger data sets, 







Microfluidic Flow Cell Array-Surface Plasmon 
 Resonance Microscope 
SPR microscopy is an ideal tool for probing large microarrays of biomolecular binding 
interactions and can provide label-free, real-time analysis of binding kinetics. Creation of 
a high-density and high-activity microarray on the SPR sensing surface is a key step in 
SPRM analysis. Various microarray fabrication techniques, such as protein pin spotting, 
ink jet printing and micro contact printing, have been used to create large numbers of 
densely arrayed spots.
18, 19
  However, disadvantages of these ex situ arraying methods 




  Microfluidic technology provides an alternative approach to in situ array fabrication 
and biomolecule immobilization.
22, 23
 A continuous flow microspotter (CFM) is a 3D 
microfluidic system that was developed by Gale and coworkers for microarray 
fabrication with continuous flow.
24
 The confinement of protein deposition to specific 
locations on the substrate with CFM can minimize sample depletion in 2D microfluidic 
channels and increase the array density. When CFM was integrated with SPR microscope 
for the first time in our lab, the capability to perform sequential assay steps with 
continuous flow enabled the integrated system for in situ immobilization of probe 
molecules and analysis of target in solution in a microarray format. In addition to the 
advantages of real-time, label-free and high-throughput analysis with SPR microscope, 
the in situ method shows improved deposition quality,
24
 and maintaining a humid 





research, we will focus on the setup of the integrated system, optimization of experiment 
conditions and applications in analyses of various biomolecular interactions.  
In Chapter 2, we demonstrate the integration of the CFM as a microfluidic flow cell 
array (MFCA) with an SPR microscope (SPRM) for in situ microarray fabrication and 
real-time analysis. Antibody-antibody interactions are chosen as the model system to 
demonstrate the capability of the combined MFCA-SPRM system.  
In order to optimize conditions for array-based biomolecular interaction analysis with 
the MFCA-SPRM, binding kinetics of biotin-streptavidin and Daclizumab (a humanized 
monoclonal antibody drug)-IgG are studied as model systems in Chapter 3 to probe the 
impact of physicochemical parameters, such as concentration of reactants in solution and 
on the surface, flow rate and geometry of flow cell, on the performance of MFCA-SPRM 
system. The study is based on both experiments and numerical modeling. The modeling 
is useful for the evaluation of factors that impact different biomolecular interactions 
under a variety of conditions. Sources that cause signal variations among microspots are 
also identified in Chapter 3. 
The application of the MFCA-SPRM system for biomolecule analysis is described in 
Chapters 4-6.  In Chapter 4, a preliminary investigation of applying the MFCA-SPRM to 
detect and measure antidrug antibodies (ADAs) from serum samples of multiple 
sclerosis patients treated with Daclizumab is reported. Measurement of ADAs is one of 
the approaches to evaluate the immunogenicity of biological drugs. The assessment and 
monitoring of immunogenicity are necessary in clinical trials of new drugs for safety and 
efficacy. Bioanalytical methods including radiolabeling, enzymatic, fluorescence, 





immunogenicity assays in various formats, such as direct, indirect, bridging and 
competitive. In addition to reported label-free, real-time immunogenicity assays with 
SPR, MFCA-SPRM provides more channels for high-throughput analysis and 
opportunities for multiple simultaneous control experiments.  
Chapter 5 describes a versatile method to use MFCA to fabricate antibody arrays and 
then identify surface-bound antibodies after SPR analysis with a commercial MALDI-
TOF mass spectrometry. The ultimate goal is to combine SPR and MALDI MS for array-
based qualitative and quantitative analyses of protein interactions. Chapter 6 presents the 
characterization of intact vesicles immobilization on SPR sensing surface, which could be 
applied in protein-membrane interaction analysis. The interfacial energy of vesicles 
adsorption depends on several factors including the hydrophilicity of the surface as well 
as the composition and size of vesicles. A calculation model is proposed to relate SPR 
signals with structures of the vesicles on the solid surfaces. 
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Figure 1.1. Properties of surface plasmon polaritons at a dielectric-metal interface. (a) 
SPPs are transverse electromagnetic waves propagating in the x-positive direction. (b) 
The exponentially decayed electric fields of SPPs in metal and dielectric medium. (c) The 
dispersion curves of SPPs and a photon in free space. Reprinted by permission from 
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CHAPTER 2 
MFCA-SPRM SYSTEM FOR IN SITU MICROARRAY 
FABRICATION AND THE STUDY OF 
BIOMOLECULE INTERACTIONS 
Introduction  
In this chapter, the integration of a microfluidic flow cell array (MFCA) with a surface 
plasmon resonance microscope (SPRM) is described. After integration and initial 
characterization, a high-throughput approach to SPRM calibration, microarray fabrication 
and biomolecular interaction analysis demonstrates the multiplexing capability of the 
integrated MFCA-SPRM system.  
SPR-Based Biosensors 
SPR-based sensors have been widely used in analyses of biomolecular interactions in 
biomedical, pharmaceutical, food and environmental research.
1
 Based on the coupling 
approaches leading to excitation of surface plasmons,
2
 SPR sensors can be categorized 
into three types: prism, grating and waveguide coupled. The most common SPR sensors 
are built with a prism coupler because of the simple configuration. Depending on the 
detection modulation, a prism-based SPR system can be set up in either SPR 
spectroscopy or SPR microscopy (also called SPR imaging) modes.
3, 4
 SPR spectroscopy 
typically relies on measuring the minimum intensity of reflected light versus 
15 
 
wavelength or angle of the incident light.
5 
 However, this spectroscopy mode is often 
limited in terms of running multiple experiments simultaneously. The image based 
microscopy format provides spatially-resolved measurements and has extended SPR-
based sensing to a microarray format. In addition to the label-free and real-time analysis 





SPR Microscopy (SPRM) is based on using an expanded and collimated light source 
to probe a large region of a sensor surface and a CCD camera to monitor the reflected 
light intensity from the entire sensing region to form a digital image (Figure 2.1a).
11
 The 
intensity values for selected pixels in the generated gray-scale images can be correlated 
with the amount of material adsorbed on the sensor surface.
9, 12
 The microscopy format 
provides parallel processing advantages of larger data sets, opportunities for multiple 
simultaneous control experiments, and improved statistically significant results. 
The ability to analyze biomolecular interactions in a real-time, label-free and high-
throughput manner has made SPRM an attractive option for protein microarray 
studies.
9, 13-15
 In order to apply SPRM, deposition and arraying technology must be used 
to functionalize the sensing surface and create the microarray. Protein pin spotting, ink jet 
printing, microcontact printing and other surface patterning techniques have been used to 
create microarrays of biomolecules, such as DNA,RNA and protein microarrays shown in 
the top row of Figure 2.1b.
9, 16, 17
 Typically, these microarray fabrication is done ex situ, 
introducing potential protein denaturation and conformation changes due to drying of the 
surface.
18
 Other disadvantages of traditional arraying include poor spot quality, extensive 
16 
 




 In addition, 
array fabrication suffers from inadequate methods to characterize protein immobilization 
and to quantify immobilized probe molecules. 
Microfluidic Flow Cell Array 
Microfluidic technology provides an alternative approach to address challenges related 
to array fabrication and biomolecule immobilization.
21, 22
 When a microfluidic system is 
used to deliver biomolecules, mass transport to regions of the sensor surface is 
significantly enhanced as diffusion lengths are minimized and convective transport 
replenishes sample across the surface.
23
 Two-dimensional (2D) microfluidic approaches 
have been used in conjunction with SPRM as shown in the bottom row of Figure 
2.1b.
24-28
 2D microchannels or two sets of perpendicular microchannels are used to 
deliver biomolecules to the functionalized SPR sensing surface.  However, these 
microfluidic systems are limited by the density that can be achieved and the extended 
lengths of the regions that are created leading to sample depletion problems. Sample 
adsorption to the surface of the microchannels can be reduced through blocking agents; 
however, sample depletion during immobilization still occurs leading to a decrease in 
sample near the end of the reaction zone due to the large reactive surface region defined 
by the microfluidic lanes. The large regions of immobilized probe also can lead to a low 
target surface density which may impact detection limits. Due to these problems, high 
probe concentration is needed for immobilization to avoid the formation of a gradient of 
probe densities on the sensor surface.   
Recent microfluidic developments have focused on three-dimensional (3D) 
microfluidic networks to confine deposition to specific locations on the substrate in order 
17 
 
to minimize sample depletion and increase array density. One example is the 
development of the 3D continuous flow microspotter (CFM). Gale and co-workers 
demonstrated a dramatic increase in spot uniformity and quality for the CFM compared 
with standard pin-spotting microarray fabrication.
29, 30 
Despite the advantages of the 
CFM, the problem of performing the spotting step ex situ and separate from the detection 
step remains, and can lead to potential protein denaturation, contamination, and delayed 
assay time. Also the ability to perform large numbers of separate, simultaneous 
experiments is eliminated due to the use of a single or limited-channel flow cell used for 
the detection step of array-based assays.
31, 32
 
In this chapter, we demonstrate the integration of the CFM as a microfluidic flow cell 
array (MFCA) directly with an SPR microscope for in situ microarray fabrication and 
real-time analysis. The MFCA enables simultaneous operation of 48 separate 
microfluidic cells to address 48 individual sensing regions on a SPR sensor surface using 
an SPR microscope as the detector. We used 24 of the available microfluidic cells; 
however, a modification to the fluidics control would allow addressing all 48 cells. Even 
larger numbers of channels could be used in a 96-channel MFCA that is under 
development.  
The MFCA-SPRM system enables microarray based analysis using both SPR intensity 
and angular modulations. The SPR microscope is set up in the Kretschmann 
configuration. The circular sensing area has a diameter of approximately 1 cm, which is 
well suited to integration of the microfluidic flow cell array (MFCA), which has a 
rectangular area of 0.5 × 1 cm. A multichannel peristaltic pump is adopted to load 
samples into each flow cell of the MFCA simultaneously at the same flow rate. 
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Continuous-flow deposition of biomolecules on the SPR sensing surface can be used for 
in situ microarray fabrication and multiplexed biomolecular interaction analysis. Ethanol 
and water mixtures are used to test the SPR response to changes in the bulk refractive 
index with intensity modulation.   
Experimental 
Materials 
Biotin-terminated tri(ethylene glycol) hexadecane thiol (BAT) and 1-mercapto-11-
undecyl tetra(ethylene glycol) (OEG) were purchased from Asemblon (Redmond, WA). 
Immunopure streptavidin (SA), human IgG (Ab2), and biotin-conjugated goat anti-
human IgG (Ab1) were used as received from Pierce (Rockford, IL). Absolute ethanol 
was purchased from AAPER Alcohol (Shelbyville, Kentucky). Nanopure water was 
obtained using a Barnstead Nanopure Diamond purification system, and used to prepare 
phosphate buffered saline (PBS, 150 mM NaCl, pH 7.4). A solution of 0.5% sodium 
dodecyl sulfate (SDS) was prepared to clean the flow system and a 0.5% Tween 20 
solution was flowed through the MFCA to overcome nonspecific adsorption. 
SPRM-MFCA System 
The SPR microscope is custom-built and is similar to a previously described system.
33
 
The layout of the microscope components is presented in Figure 2.2. An intensity-
stabilized HeNe laser from Melles Griot (Carlsbad, California) is used as a light source. 
The laser beam is expanded and collimated by optics from Newport Corporation (Irvine, 
CA) before traveling through a SF14 hemispherical prism (R. Mathews Optical Works, 
Poulsbo, WA) and SF14 substrate (Refractive Index 1.7618) from Schott AG (Elmsford, 
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NY). The filter is an absorptive neutral density filter. L1 is a plano-concave lens 
(KPC025AR.14); L2 is a plano-convex lens (KPX119AR.14). These two lenses work as 
a beam expander. L3 and L4 are precision achromatic doublet lenses (PAC040AR.14) to 
focus the beam light. The substrate is coated with 2 nm of titanium or chromium and 50 
nm of gold using a Denton electron-beam evaporator. The reflected light is detected by a 
CCD camera (IMB-3145FT) from k-Space Associates (Ann Arbor, MI). Two rotation 
stages from Newport Corporation (Irvine, CA) are used to control the angles of incidence 
and reflection of the laser beam. The whole system is mounted on a laser table. An 
imaging angle of 54.8º was used for the experiments described in this chapter. Software 
from k-Space Associates (Ann Arbor, MI) was used to acquire and process images. For 
real-time analysis, detection windows of specific pixels were put in the regions of interest 
(ROIs) in the SPRM image, and intensity signals from ROIs were collected with one-
second time resolution. The MFCA was integrated into the SPRM optical system with a 
custom-made manifold mounted on an X-Y stage from Newport Corporation (Irvine, 
CA). The pressure to push the MFCA tip against the substrate was adjusted by 
controlling the position of the stage.  
Microfluidic Flow Cell Array 
MFCAs (Wasatch Microfluidics, Salt Lake City, UT) were fabricated in 
polydimethylsiloxane (PDMS) by adapting soft lithography methods and using injection 
molding to increase throughput as described previously.
30
 Master molds were fabricated 
by micromilling the pattern in brass to the proper dimensions. A polycarbonate replica 
was made and used for casting the PDMS devices. Multiple layers of PDMS were bonded 
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 A 24-channel peristaltic pump from Ismatec (Glattbrugg, Switzerland) was used for 
loading samples and driving solutions through the MFCA.  The peristaltic pump contains 
eight rollers to minimize pulsing in the flow rate.  Distinguishable pulsing was noticed at 
flow rates above 250 µL/min.  In order to avoid pulsing issues, we used flow rates in the 
range of 20−100 µL/min; optimization of the flow rate will be discussed in Chapter 3. 
PTFE tubing (0.012" ID x 0.030" OD from Cole-Parmer) connections to the MFCA were 
cut to the same length to maintain the same volume across all of the channels. Platinum-
Cured Silicone Tubing (3 mm long, 0.020" ID x 0.083" OD from Cole-Parmer) was used 
as a connector between the PTFE tubing and channels. The MFCA fluidic design ensures 
nearly simultaneous fluid arrival to each region on the sensor surface. Confirmation of 
the flow rate was achieved by injecting fluids with different refractive indices and 
monitoring their arrival to the surface with the SPR microscope.  
Rotation Stage Control 
In Figure 2.2, simultaneous control of the angles of incidence and reflectance in the 
SPRM is based on mounting the prism on stacked rotation stages. Both stages are driven 
by an ESP 300 motion controller/ driver from Newport Corporation (Irvine, CA). The top 
stage is used to change the light incident angle and the bottom one is to control the 
position of CCD camera to detect the intensity of reflected light. In order to generate the 
real-time SPR angle curve that is based on a plotting the reflected light intensity versus 
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the angle of incident light, the top stage (stage 2) is slaved to the bottom one (stage 1) and 
the angles are changed simultaneously. The moving angle ratio of stage 2 to stage 1 is 
0.5, which means the rotation angle of stage 2 is as half that of stage 1. Detailed 
commands used to control the stages are listed below: 
1MO; 2MO //Turn stage 1, 2 on 
1OR; 2OR // Move stage 1, 2 to absolute 0 
2SL-90; 2SR90 // Set moving angle rang of stage 2  
2PA-45 // Move stage 2 to angle -45.00 
2SS1; 2GR-0.5 // Set stage 2 slaved to stage 1 and their moving angle ratio 
1TJ1; 2TJ4 // Set trajectory mode for stage 1, 2 
1SL-90; 1SR90 // Set moving angle rang of stage 1 
1AC1; 1VA0.1 // Set the accelerate rate and moving rate of stage 1 
Detection Methods 
For real-time analysis, windows with specific pixel height and width are placed in the 
regions of interest (ROIs) in the SPRM image. An example of the selection of ROIs is 
shown in Figure 2.4a. There are two detection modulations: angular and intensity 
modulation. With the angular modulation, the flow in the flow cell is stopped while the 
rotation stages are moved. Rotation stages are moved to tune the light incident angle for 
SPR coupling conditions and intensity of reflected light is measured at the detector as 
described in Chapter 1.  At one specific angle, the SPR coupling reaches a maximum and 
the intensity of reflected light drops to a minimum. This angle is called the SPR angle, 
which is a characteristic of solution of this refractive index (RI) as described by Equation 
1.1 and 1.2. The same equations show that higher RI solution has higher SPR angle, so 
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the SPR angle curves shift to larger angles with increasing value of RI in Figure 2.3b. For 
example, the SPR angle curves shift to larger angles when the solution in flow cell 
changes from water to protein because protein has larger RI value. From the SPR angle 
curves in Figure 2.3b, if we collected the signal at a fixed angle, the light intensity 
increases when the solution changes from water to protein. This is the intensity detection 
mode we used to measure the adsorption of protein with continuous flow and the 
detection curves are shown in Figure 2.4c. At a fixed angle and within a small range of 
RI, the intensity increases linearly with an increasing RI, so we can monitor the RI 
change with time by measuring the intensity change of reflected light. The intensity 
modulation is especially useful for biomolecular interaction analysis since the SPR 
curves provide information for both kinetic and quantitative analysis.  
Surface Coverage Calculations 
SPR sensing is based on the excitation of SPPs at a metal-dielectric interface. The 
propagating charge density waves create an evanescent electromagnetic wave extending 
several hundred nanometers above the sensor surface. Under energy and momentum 
matching conditions, incident light couples with the SPPs leading to a loss of reflected 
light at a specific wavelength or angle, depending on the instrument configuration. 
Binding events occurring within the evanescent wave result in local effective refractive 
index (      changes at the metal-dielectric interface leading to a shift in the wavelength 
or angle of coupling (i.e., SPR wavelength or SPR angle). SPR angle curves in Figure 2.5 
are from theoretical calculations of SPR angle shift caused by the change of bulk 
refractive index adjacent to a gold surface. Within the linear regime defined in Figure 2.5, 
the change in reflected light intensity can be related to changes in effective refractive 
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index due to molecules binding to the SPR sensor surface. The linear relationship is 
shown in Equation 2.1.
33, 34
  
                                                                    
where    is the shift in light intensity and   is the refractive index of solvent.       
    Is the change of local refractive index.   is the sensitivity factor, which can be 
experimentally determined by a calibration plot of    versus the change of bulk refractive 
index.
33
 s depends on the slope of the SPR angle curve in Figure 2.5 and the sensitivity 
factor of the SPR angle curves, which is also experimentally measured by plotting the 
SPR angle shift versus the change of local refractive index. 
 Effective refractive index (      is a properly weighted average of refractive index of 
the dielectric medium that consists of any adsorbed layers and the bulk solution. It is 
given by Equation 2.2 and proved to be accurate by Maxwell’s equations.33, 34  
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where      is the refractive index at height z and    is the decay length of the evanescent 
field at the metal-dielectric interface.  
   For an adsorption layer of thickness of d,      =    for 0 < z  < d ,     is the 
refractive index of adsorbed layer;      =    for 0< z< . The integral of Equation 2.2 
gives 
                                                  (     
   
  )                                           
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Combining Equation 2.1 and 2.3 gives 
  
  
        
  
   
                                                                    
Taking the natural logarithm of both sides in Equation 2.4, and in the case of d is very 
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Multiplying the thickness d with the density of molecules can be used to estimate the 
surface coverage of adsorbed molecules. 
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where ηp and  ηs are the refractive indices of protein and buffer, respectively. We used a 
value for ηp  of 1.57
34
  and ηs  was measured using a refractometer. Mw is the molecular 
weight of the protein. ρ  is the density of protein and typically equal to 1.37 g/cm.
3, 33, 34 
NA is Avogadro’s number. ld is the decay length of the evanescent wave, which was 
assumed to be 300 nm as derived from Maxwell’s equation.33 The value for s, the SPRM 




SPR Microscope Sensitivity Measurement  
The SPR microscope’s response to bulk refractive index changes was characterized by 
preparing mixtures of ethanol and Nanopure water. The refractive indices of the 
solutions (ethanol/water) were measured using an Abbe-3L refractometer from Milton 
Roy (Rochester, NY).  
Self-Assembled Monolayer (SAM) Formation 
Gold-coated glass substrates were immersed in 0.1 mM mixed BAT and OEG 
solutions (BAT:OEG mole ratio of 1:9) for 24 h to form a mixed-SAM on the surface. 
Then the substrate was removed from the solution, rinsed with pure ethanol, and dried by 
a stream of nitrogen. Finally, the substrate was mounted on the planar face of the SPRM 
prism with refractive index matching liquid (Refractive Index 1.7600 ± 0.0005) from 
Cargille Laboratories (Cedar Grove, NJ).  
Antibody-Antibody Interaction Analysis 
As shown in Figure 2.5, a streptavidin (SA) layer was formed on the mixed SAM by 
introducing SA solutions (100 μg/mL SA in PBS) using the MFCA. Next, biotin-labeled 
goat anti-human antibody (Ab1, 1:100 dilutions in PBS) was introduced and adsorbed on 
the SA-coated surface. In the final step, human IgG (Ab2) was delivered at 
concentrations of 6, 12, 25, 50, 100 and 200 µg/mL. All steps of SA and Ab1 
immobilization as well as Ab2 binding were monitored by SPRM. Twenty-four 
microfluidic channels of the MFCA were employed with one channel serving as a 
control. The microarray creation and antibody assay takes about one hour. 
26 
 
Results and Discussion 
SPR Microscope Sensitivity Measurement 
The response of the SPR microscope to bulk refractive index changes was 
characterized by preparing mixtures of ethanol and water. The refractive indices of the 
solutions (ethanol/water) were measured by an Abbe-3L refractometer from Milton Roy 
(Rochester, NY). The calibration provides characterization of SPRM sensitivity and 
monitoring of the MFCA flow control. In the calibration, six solutions containing 
different volume ratios of water/ethanol with different bulk refractive indices (RI) were 
loaded into the inlet wells and flowed through the microfluidic cells at the 
substrate/MFCA interface and into the outlet wells. Water was used to establish a 
baseline between introductions of each calibration solution. Figure 2.6b presents the in 
situ, real time SPRM response to the bulk RI changes monitored in ROIs in the 24 flow 
cells of Figure 2.6a. The good overlap of the rise and fall time points demonstrates the 
uniform channel flow rates which are important for minimizing variations in kinetic data 
because of flow rate effects. The SPR response to each solution is uniform with relative 
standard deviations (RSDs) of less than 10%. The major cause of signal deviations is 
from optical system, which will be discussed in Chapter 3. The sensitivity factor of the 
SPR microscope was calculated by averaging the slope of plots shown in Figure 2.6c. 
The sensitivity factor is used to calculate surface density of biomolecules and estimate 
the dynamic range of detection. The average sensitivity factor for 24 flow cells is 2905% 
reflectivity/RIU and the dynamic range is 0.01 RIU, which is comparable to that reported 
from a similar SPRM system(3576 ± 332% ).
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Microarray Fabrication and Real-time Biomolecular 
 Interaction Analysis 
A long-term goal for the application of the integrated MFCA-SPRM system is to 
develop immunogenicity assays which are used to screen anti-drug antibodies from 
serum or blood samples of patients treated with biological drugs such as the humanized 
antibody drug Daclizumab. An antibody-antibody interaction that mimics an 
immunogenicity assay was used to demonstrate the capability of the system. The first 
step in this assay development is immobilization of the probe antibody on the SPR sensor 
surface. The integrated MFCA-SPRM system was used to control and monitor in situ 
antibody immobilization as part of the array fabrication process. We used a well-
characterized, versatile immobilization strategy based on a tethered streptavidin layer 
formed on a mixed self-assembled monolayer (SAM).
12
 The SAM-functionalized gold-
coated substrate was mounted on the SPRM prism using refractive index match fluid. 
 Figure 2.7a shows real-time adsorption data from the in situ array fabrication and 
antibody binding assay. Adsorption on the sensor surface was tracked by measuring 
changes in the SPRM response in ROIs within the MFCA in the image. A baseline in 
SPR response plot was established with PBS buffer. Next, SA was introduced into the 
flow cells. The SA bound to the biotin groups on the SAM-covered substrate surface is 
shown in Figure 2.7b. The concentration used resulted in a saturation level of SA on the 
surface to create a nearly close-packed SA layer. This binding surface was used to 
capture biotinylated goat antihuman IgG (Ab1). The immobilization of the probe 
antibody Ab1 also was followed in real time as shown in Figure 2.7a. Finally, the 
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adsorption of the target human IgG antibody (Ab2) was monitored as the antibody was 
introduced at different concentrations. 
The changes in percentage reflectivity from the SPRM measurements were converted 
to surface coverage using published methods.
9
 The average SA surface coverage of (11.3 




 is in agreement with reported values for saturation coverage 
of SA on the mixed BAT/OEG-containing SAM.
33
 The average surface coverage of goat 




. The Ab1/SA binding ratio 
of 0.5 is consistent with the expected Ab1 surface density based on the dimensions of the 
molecules. After probe Ab1 immobilization, solutions containing different concentrations 
of Ab2 were introduced in multiple channels simultaneously. Figure 2.7a shows the real-
time Ab2 adsorption curves. Because the probe immobilization was performed in situ and 
quantified using the SPRM response, the target Ab2 adsorption for each MFCA 
microfluidic channel can be normalized using the Ab1 coverage for the corresponding 
ROI. The normalized responses for different bulk solution Ab2 concentrations are shown 
in Figure 2.7b. The average binding ratio of Ab2/Ab1 (Figure 2.7b) indicates that the 
average activity of immobilized Ab1 is greater than 60%, which is consistent with  value 
reported  by Peluso etc.
15
 The RSD in the % reflectivity for Ab2 concentrations of 6, 12, 
25, 50, 100, and 200 μg/mL were 1.7, 3.1, 2.7, 8.4, 5.3 and 16.5% reflectivity, 
respectively. Control experiments (data not shown) showed negligible non-specific Ab2 
adsorption on the SA layer without Ab1 at concentrations of 250 µg/mL, so the higher 
RSD for 200 µg/mL is not due to non-specific adsorption. In Chapter 3, we will 
characterize the microfluidic behavior of the MFCA and investigating the impact of 
changes in microfluidic parameters (e.g., flow rate, contact time, and cycling) on 
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biomolecule delivery and binding which may provide insight into how to reduce the RSD 
values for the Ab2 adsorption measurements. 
Figure 2.8 presents the concentration-dependent SPRM response to different Ab2 
solution concentrations. The same SA and Ab1 immobilization process as described 
above was followed before the SPRM response to a series of solutions with different Ab2 
concentrations was monitored. Each data point is an average of three or four 
measurements from a single multichannel experiment. The binding isotherm of Ab2 to 
surface-immobilized Ab1 shows that the Ab2 adsorption reaches a saturation level at Ab2 
concentrations above 20 μg/mL. The Ab2/Ab1 binding ratio indicates this saturation 
occurs at 60−70% maximum occupancy of the Ab1 on the surface which is typical for the 
SA-immobilized Ab1. The inset in Figure 2.8 shows the linear trend in the response when 
the Ab2 solution concentration is plotted on the log scale. We found the limit of detection 
for this particular antibody pair based on a signal greater than three times the noise to be 
approximately 80 ng/mL which is well below the industry recommended assay detection 
limit of 500 ng/mL for immunogenicity assays.
35
 The correlation of the minimum 
detectable signal with concentration of analyte in solution depends on the affinity 
constant for the interaction between the target analyte (e.g., Ab2) and the probe (e.g., 
Ab1) immobilized on the sensor surface and will need to be determined for specific 
biomolecules. The linear dynamic range of the SPRM is 0.01 RIU which is equivalent to 
approximately four close-packed layers of protein. This dynamic range allows 
measurement of all steps of probe immobilization and target binding without the need to 
adjust the SPRM imaging angle. If the change of refractive index exceeds the detection 
30 
 
range, the imaging angle could be adjusted between steps in an experiment which would 
extend the linear dynamic range.  
Conclusions 
The MFCA-SPRM integration represents a significant step forward in the throughput 
of SPR-based analysis which has been one of the major obstacles for the expansion to 
applications outside of kinetic analysis. The parallel performance capability of the MFCA 
dramatically increases the number of options available in planning experiments. 
Optimization of probe immobilization and microarray fabrication can be performed in a 
single experiment including controls and replicates. Biomolecule interactions in different 
buffers and flow conditions can be investigated on the same sensor chip. Concentration 
analysis for biomarker screening is a more realistic option with the ability to create 
standard curves while screening separate analytes with a statistically relevant number of 
replicates. The current MFCA configuration enables 48 separate flow cells in a 4 mm × 
10 mm footprint. On-going development of the MFCA is focused on shrinking the overall 
spot size and increasing the density of flow cells within the same footprint (e.g., 96 and 
192 channels). Future studies toward the development of immunogenicity assays based 
on the integrated SPRM-MFCA system will involve immobilizing an antibody-based 
drug as a probe to assay for target antidrug antibodies from patients’ sera. In addition to 
immunogenicity assays, the integrated system also could be applied in biomarker 
screening and extended to array-based, label-free analysis of a wide range of molecular 
interactions involving proteins, nucleic acids, lipids, and carbohydrates. The flexibility of 
the MFCA also provides the option for application to other sensing platforms (e.g., 
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Figure 2.1. SPR imaging for microarray-based analysis of biomolecule interactions. (a) 
Schematic of SPR microscopy (SPR imaging) setup based on a prism coupler. (b) 
Bimolecular microarrays created on SPR sensing surface to study various biomolecular 
interactions, the top row is DNA microarrays fabricated by a combination of self-
assembly and UV photo patterning to study interactions of DNA, RNA and protein with 
immobilized DNA; and the bottom row are carbohydrate, peptide and protein surface 
patterns or microarrays made by 2-dimensional microchannels for the study of their 
interactions with protein.  Reprinted with permission from {Lee et al. Langmuir 2006, 22, 
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Figure 2.2. Schematic design of the SPR microscope based on the Kretschmann 
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Figure 2.3. Photos and schematic structure of MFCA. (a) Photo showing top view of the 
MFCA. The MFCA tip extending out from the main rectangular area is shown in more 
detail in (b) and (c). (b) Photo of the MFCA tip face. The 48 openings comprise the 48 
microfluidic cells when the face of the tip is sealed against a substrate. (c) Top view of a 
row of joints where the inlet and outlet microchannels meet. (d) Schematic of the layered 
MFCA structure and the relationship between the channels and the sample wells. (e) 







































































Figure 2.4. Detection modes of SPRM-MFCA. (a) SPRM image of 48 microfluidic cells 
filled with water. ROIs are selected by selecting pixels in the image. The 400 × 400 µm 
windows appear as rectangles rather than square in the SPRM image because of the 
imaging angle used. (b) SPR real-time curves with angular modulation show that the SPR 
angle shifts to right with increasing value of refractive index. (c) SPR real-time curves 
with intensity modulation show that the intensity of light increase with molecules 



























































Figure 2.5. SPR reflectivity curves of infinitely thick layers of two refractive indices. 
Solutions of 1.3330 (black) and 1.3342 (gray) in contact with a 47.5 nm gold film on an 
SF14 prism illuminated by 632.8 nm wavelength light are predicted from Fresnel 
calculations. Reprinted with permission from {Shumaker-Parry et al. Analytical 
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Figure 2.6. SPRM calibration using 24 microfluidic cells of MFCA. (a) SPRM image of 
24 microfluidic cells filled with water. The image was acquired at an incident light angle 
of 54.8°. (b) SPRM curves showing the system response to solutions with different 
refractive indices. A CCD camera with acquisition software was used to measure 
reflected light intensity from 20 × 20 pixel ROIs selected from the SPRM image for each 
microfluidic cell. The legend shows each curve and the position of the corresponding 
MFCA microfluidic cell in the SPRM image in (a). The refractive indices of the solutions 
are (baseline) 1.3320, (P1) 1.3331, (P2) 1.3340, (P3) 1.3350, (P4) 1.3370, (P5) 1.3396, 
and (P6) 1.3421. (c) SPRM responses from (b) are used to obtain the average SPRM 
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Figure 2.7. In situ microarray fabrication and analysis with SPRM-MFCA. The data was 
acquired at an incident light angle of 54.8°. (a) Cartoon of adsorbed layers and real-time 
adsorption/desorption curves for microarray creation and antibody binding on a SAM-
coated gold SPR sensor. The baseline of the plots corresponds to PBS buffer flowing 
through the MFCA cells. After introduction, SA binds to the biotin-containing SAM. 
Next, biotinylated goat antihuman IgG (Ab1) binds to the SA-coated surface. Finally, 
solutions with different human IgG (Ab2) concentrations were introduced to the Ab1 
surface. Each letter/color represents a different Ab2 concentration, and each number 
signifies a different MFCA cell. The Ab2 concentrations were A = 6 μg/mL, B = 12 
μg/mL, C = 25 μg/mL, D = 50 μg/mL, E = 100 μg/mL, F = 200 μg/mL. (b) Ab2 
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Figure 2.8. The equilibrium SPRM signals of Ab2 adsorption versus different Ab2 
solution concentrations. Each data point represents an average response calculated from 
at least three individual adsorption curves. All data points were measured simultaneously 
in a single experiment. The inset shows the linear relationship before saturation when the 






























































































































OPTIMIZATION OF MFCA-SPRM FOR BIOMOLECULAR 
INTERACTION ANALYSIS BY STUDYING MASS 
TRANSPORT AND SURFACE 
 HETEROGENEITY 
Introduction 
As described in Chapter 2, the MFCA-SPRM is a newly developed, integrated SPR 
system for in situ microarray fabrication and multiplexed analysis of biomolecular 
interactions with multi-channel fluidics control. Biomolecular interactions involve 
multiple-step reactions between analytes in solution and ligands on the surface. 
Obviously, the concentration of reactants plays a key role in the reaction rate at the solid-
liquid interface. The reactive analyte concentration is directly impacted by mass transport 
and the diffusion coefficient of the analyte. In order to improve the integrated system for 
rapid and sensitive microarray analysis, parameters impacting mass transport and the 
surface reaction, such as flow rates, concentration of reactants and rate constants, are 
investigated by both numerical simulation and experiments in this chapter. 
Immunoassays based on microfluidics are emerging as an important technology for 
life science research, disease diagnostics and drug discovery because of low cost, small
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sample volume and short analysis time.
1, 2
 Microfluidic immunoassays can be classified 
as homogeneous or heterogeneous, depending on whether the reaction is in solution or 
interfacial. Heterogeneous immunoassays utilize probe molecules immobilized on a solid 





 or label-free sensing approaches, 
such as surface plasmon resonance (SPR),
5, 6







 Regardless of the detection method or the 
immunoassay format (e.g., direct, indirect or competition), kinetics of heterogeneous 




Generally, with a pressure-driven flow, analytes are delivered to the reaction surface 
by convection and diffusion described by the Navier-Stokes equations.
13
 From the 
equations, factors that impact the interactions at the surface include the bulk 
concentration, flow velocity, geometry of the flow cell, diffusion constants of analytes 
and time. After arriving at a reaction surface, analytes react with ligands to form binding 
pairs, and the reaction rate depends on the surface density of binding sites and reaction 
constants, such as adsorption and desorption rate constants. Effects of these parameters 




The typical simulation approach uses finite element analysis software such as 
COMSOL Multiphysics to model the process of convection, diffusion and reaction 
simultaneously.
17-19
 Generally, the model is simulated under the assumption of 
unidirectional 2D laminar flow where the reaction surface is parallel to the flow direction. 
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Theory of this type of computational model can be found in the background information 
below. Results from simulation predict kinetics of reaction and can inform the 
optimization process and selection of experimental conditions for immunoassays. For 
example, Parsa et al. used modeling to investigate the output of a direct binding assay in 
microchannels when constrained by limited sample volume and assay time.
17
 Fu et al. 
used a 2D model to improve the sensitivity of a competitive assay based on SPR 
imaging.
18
   
In our study, a combination of simulation and experiment was applied to optimize the 
conditions for immunoassays based on the MFCA-SPRM system. Physicochemical 
parameters, such as concentration of analytes in solution and ligands on surface, flow rate 
and binding affinity, and kinetics of binding reactions were investigated in the study. The 
simulation approach was built on a 2D model to calculate the concentration of surface 
binding pairs by varying a set of physicochemical constants. The 2D modeling results 
have shown that binding kinetics from the modeling does not fit perfectly with the 
experimental results.
20
 The discrepancies in the modeling could be due to the 
experimental condition being more complex or an improper setting of parameters. 
However, the prediction from modeling is useful to estimate the trends caused by changes 
in physicochemical parameters. The experimental optimization was carried out with two 
model systems: (1) the binding of streptavidin to a binary biotin-terminated self-
assembled monolayer (SAM) thiolate surface and (2) the binding of anti-human IgG to 
biotinylated-Daclizumab surface. The first model system was selected to optimize the 
process of creating a high-density and high-activity antibody microarray. The surface 
density of biotin was controlled by varying the solution mole ratio of two different thiols. 
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The mixed SAM surface was also characterized with XPS and AFM.  Streptavidin 
solutions of various concentrations were flowed over SAM surfaces to find the optimal 
concentration, sample volume and contact time. The second model system was selected 
to mimic an immunogenicity assay, which was used to screen anti-drug antibodies from 
samples. Daclizumab is a humanized antibody drug and was immobilized on a 
streptavidin-covered surface via biotin-streptavidin interaction. A series of concentrations 
of anti-human IgG were flowed over the Daclizumab surface at various flow rates to 
improve the sensitivity of the assay.  
Finally, in order to apply the MFCA-SPRM for parallel analyses with minimum spot-
to-spot variations, a test of bulk refractive index change and protein adsorption within 24 
micro flow cells is presented. Signal variations caused by the optical system and surface 
heterogeneity are identified and the findings will be used for future experiment design.  
Background 
Model System 
The MFCA is a 3D flow system that consists of 48 micro flow cells. Each flow cell is 
connected to inlet and outlet wells via microchannels in a platform that resembles a 96-
well microtiter plate.
21, 22
 Sample solutions flowed over the sensing surface are driven by 
a peristaltic pump through microchannels and connection tubing. A 2D schematic 
structure of a single flow cell created when the MFCA is sealed with the SPR sensing 
surface for a binding reaction is shown in Figure 3.1.  The inlet and outlet channels for 
flow entering and exiting are perpendicular to the reaction surface. In order to understand 
the  mass transport and reaction process happening at the SPR sensing surface, 
Commercial CFD software, Comsol Multiphysics (Stockholm, Sweden) was used to 
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build a model to solve the Navier-Stokes and diffusion-convection equations.
20
 
Dimensions of the flow cell for numerical modeling are represented in Figure 3.2. The 
opening of the inlet and outlet microchannels are approximately 150 × 150 µm.
22
 The 
height of the flow cell is approximately 100 µm; the length of the reaction surface is 650 
µm and the width of the flow cell is of 400 µm, which is not shown in Figure 3.1.  
Simulation 
The model of the MFCA is built on coupling a 2D domain of convection-diffusion 
with a 1D boundary of a diffusion-reaction. The analyte in the solution is transported to 
the reaction surface by convection and diffusion, in which the flow rate is an important 
parameter. The flow velocity profile throughout the modeling domain can be evaluated 
with incompressible Navier-Stokes equations. For a pressure driven flow reaching steady 
state, the velocity and pressure at any point within the MFCA can be solved from the 
conservation of mass and momentum relationships described by equation 3.1 and 3.2. 
                                                                           
                                                                         
where u is the flow velocity; p is the pressure; ρ is the density; and µ is the dynamic 
viscosity. The nonslip boundary condition is assumed at the walls in Figure 3.2. The inlet 
velocity is specified as a constant and the pressure at the outlet is at atmosphere pressure.  
 The concentration of analyte at the inlet is set as a constant (   , mass transport of 





                                                                       
where c is the bulk concentration of analyte and D the diffusion coefficient of the analyte.  
 For a first order reverse reaction at the reactive interface, the material balance is 
determined by the surface diffusion and the reaction rate expression of binding pairs (   , 
   
  
                                                                    
          is the initial surface density of ligands,    is the surface concentration of 
binding pairs and    is the bulk concentration of analyte.     and      are the forward 
and reverse reaction rates. From the reaction kinetic expression above, the concentration 
of surface binding products can be described as:
15
 
        
      
  
                                                              
  
   
        
          
                                                                 
  
 
          
                                                                    
        
  
 is the surface concentration of binding products when the surface reaction 
reaches equilibrium and   is the equilibrium time.10     
The boundary condition for the materials balance at the nonreactive surface is 
insulated meaning no adsorption occurred according to: 
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In this equation,   is the normal vector to the boundary. 
The boundary conditions for the bulk coupled to the surface reaction with the molar 
flux of reactant in the bulk and the concentration of the surface reactant gives 
                                                               
The wall boundaries are set to be insulated and the inlet is set as   . While at the 
outlet, the boundary condition is set as a convective flux given by 
                                                                           
For all of the equations, the effect of temperature is not considered.  
The basic simulation process with COMSOL includes a definition of model domain, 
setting equations and constants used in the domain and boundary, mesh generation, 
computing and postprocessing.
20
 As described by the equations above, the biomolecular 
interactions in the MFCA-SPRM depend on the flow pattern and the geometry of the 
flow cell. The dimensions of the flow cell are fixed in this study.  The flow velocity 
profile was modeled previously in the 2D and 3D cases.
20
 Figures 3.2 to 3.4 show a 
process of the modeling of a biomolecular interaction within the MFCA. Figure 3.2 is the 
mesh generated within the modeling region after setting domain and boundary conditions. 
After calculation, parameters of interest can be plotted during the step of postprocessing. 
Figure 3.3 is an example of the analyte bulk concentration profile in the flow cell at a 
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specific reaction time, and Figure 3.2c is a representative plot of the surface 
concentration of binding products versus reaction time. 
Theoretical Analysis 
Because of the diverse variables used in the equations listed above, it is useful to scale 
the mass transport and reaction equations without dimensions, which helps to compare 
results in different systems.
10, 13
 The dimensionless equations are presented as follows: 
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         and    are dimensionless coordinates and    is the dimensionless time. h is the 
height of the flow cell;      and      are average flow velocities in the  
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directions, respectively.    is the inlet bulk concentration of analyte. 
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 where Pe and Da are the Peclet and Damkohler numbers, respectively. Pe is the ratio of 
convection and diffusion strength and Da is the strength of surface reaction compared to 
diffusion.   is the relative adsorption capacity and    is the dimensionless equilibrium 
dissociation constant.  
Simulation Results 
Based on equation 3.6, binding rate constants (kon and koff), reactive bulk concentration 
(c), and surface density of ligands (cs0) are key parameters that impact the binding 
reaction rate and the equilibrium concentration of binding products. Using the COMSOL 
model described above, effects of these parameters were investigated by varying the 
values applied in the model. The numbers are listed in tables below and these values 




Table 3.1 presents the value of parameters used in the modeling to examine kinetic 
changes caused by binding rate constants at various analyte concentrations. Two sets of 
kon and koff   were 10
4
  mol•s/L)-1 and 10-4 s-1, 103 (mol•s/L)-1 and 10-3 s-1, respectively. 




 mol/L were considered. Pe and Da 
are numbers to compare the strength of convection/diffusion and reaction/diffusion, 
respectively. Under the simulation conditions, the Pe number is calculated to be 1000 and 
the Da number is above 10 in both cases, which represent that for both reactions, the 
reaction rate are limited by the diffusion of molecules.  
In all reactions, the rate of change of surface concentration of binding product is 
proportional to the bulk concentration of analyte in solution. The higher the concentration 
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in solution, the more molecules diffuse to the solid surface and participate in the reaction. 
Figure 3.5 presents a plot of the formation of surface binding products versus time from 
the modeling results with constants listed in Table 3.1. A high analyte concentration of 10 
µM reaches saturation within 300 s for both sets of binding rate constants, while analyte 
concentrations below 1 µM do not reach equilibrium within 15 min of the modeling time. 
The results from the modeling are useful for optimizing experimental conditions. For 
example, if a high affinity interaction is adopted to create high-density capture surfaces, 
such as biotin-streptavidin interactions, it is better to use a highly concentrated solution to 
functionalize the surface within a short time. In order to detect an analyte of low 
concentration, extended reaction time is required and the time could also be estimated 
from the modeling.  
Flow Rate 
In a flow cell of fixed geometry, the flow rate is the only variable that could be 
changed to affect the mass transport. The flow rate effect on the binding interactions 
when using the MFCA was investigated by applying two flow rates of 16.7 and 534.4 
µL/min in Figure 3.6. Values of flow rates, the binding affinity and concentrations of 
bulk analyte used for the modeling are listed in Table 3.2. A comparison of the modeling 
results in Figure 3.4a and 3.4b shows that the kinetics of the binding reactions are exactly 
the same at two different flow rates. As discussed before, the analyte is transported to the 
reaction surface by convention and diffusion. The Pe number at the two flow rates used 
in the modeling are 4.6 × 10
4
 and 1.47 × 10
6
, respectively, which indicate that diffusion 
limits the transport of analyte from the bulk to the surface in both cases.  
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The diffusion length for mass transport from the bulk to the capture surface is 
determined by the height of the concentration boundary layer near the reaction surface. 
The boundary layer thickness is inversely proportional to the flow rate of v
1/3
. However, 
reported modeling results shows that within the modeling range of the flow rate, the 
difference of boundary thickness caused by the flow rate is not significantly affected by 
the reaction rate.
20
 Therefore, the flow rate shows little effect on the thickness of 
boundary layer and reaction rate from the modeling results. 
Surface Density of Binding Sites 
The surface density of binding sites plays a key role in determining the binding 
kinetics as expressed in equation 3.4. The surface density of binding sites with reference 




) is listed in Table 3.3 and used for 
the simulation.
21
 The modeling bulk concentration ranges from 0.1 to 20 µM and the 
simulated results are shown in Figure 3.7. The plot shows that the surface density of 
ligands determines the initial reaction rate as well as the equilibrium concentration of 
surface binding products. For reactions with the same binding affinity, the higher the 
surface density is, the faster the reaction proceeds and the more binding products are 
produced. The modeling is based on the assumption that evenly distributed binding sites 
have uniform activity on the surface. However, this assumption is also a limitation of the 
simulation. Under experimental conditions, the fractional activity of binding sites and the 
surface heterogeneity are two parameters that can cause possible different results from 






(1-Mercapto-11-undecyl) tetra (ethylene glycol) (OEG) and biotin-terminated tri 
(ethylene glycol) hexadecanethiol (BAT) were purchased from Asemblon (Redmond, 
WA). Immunopure streptavidin (Product # 21125), goat anti-human IgG (Product # 
31130) and a biotinylation kit (Product # 21445) were purchased from Pierce (Rockford, 
IL). Daclizumab in saline (1.18 mg/mL) was provided by Dr. John Rose, Department of 
Neurology, School of Medicine, and University of Utah. Biotinylated-protein A (1 
mg/mL) and mouse IgG (10 mg/mL) in PBS buffer was provided by Wasatch 
Microfluidics. Absolute ethanol was purchased from AAPER Alcohol (Shelbyville, 
Kentucky). Water was purified using a Barnstead Nanopure Diamond laboratory water 
system, and phosphate buffered saline (PBS, pH 7.4) was prepared in the laboratory. 
MFCA-SPRM System 
 The SPR microscope is custom-built and similar to a previously described system.
23
 
An intensity-stabilized, HeNe laser from Melles Griot (Carlsbad, California) is used as a 
light source. The laser beam is expanded and collimated by optics from Newport 
Corporation (Irvine, CA) before traveling through a SF14 hemispherical prism (R. 
Mathews Optical Works, Poulsbo, WA) and SF14 substrate from Schott AG (Elmsford, 
NY). The substrate is coated with 2 nm of titanium and 50 nm of gold using a Denton 
electron-beam evaporator. The reflected light is detected by a CCD camera (IMB-
3145FT) from k-Space Associates (Ann Arbor, MI). Two rotation stages from Newport 
Corporation (Irvine, CA) are used to control the angle of incidence and position of the 
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detection CCD camera. The entire system is mounted on a laser table. Software from k-
Space Associates (Ann Arbor, MI) was used to acquire, record, and process images. The 
MFCA was integrated into the SPRM optical system with a custom-made manifold 
mounted on an X-Y stage from Newport Corporation (Irvine, CA). MFCAs (Wasatch 
Microfluidics, Salt Lake City, UT) were fabricated in poly (dimethyl siloxane) (PDMS) 
by adapting soft lithography methods and using injection molding to increase throughput. 
Master molds were fabricated by micromilling the pattern in brass to the proper 
dimensions. A polycarbonate replica was made and used for casting the PDMS devices. 
Multiple layers of PDMS were combined together to form sophisticated three-
dimensional networks through partial curing of layers or oxygen plasma treatment of the 
surface. A 24-channel peristaltic pump from Ismatec (Glattbrugg, Switzerland) was used 
for loading samples and driving solutions through the MFCA. The peristaltic pump 
contains eight rollers to minimize pulsing in the flow rate. The minimum flow rate of the 
system is 16.7 µL/min.  
Biotin-Streptavidin Binding Affinity Measurement 
Gold-coated glass substrates were immersed in 0.1 mM mixed BAT and OEG 
solutions (1: 9 BAT: OEG) for 24 h to form a mixed-SAM on the surface. Then, the 
substrate was removed from the solution, rinsed with pure ethanol, and dried by a stream 
of nitrogen. Finally, the substrate was mounted on the planar face of the SPRM prism 
with refractive index matching liquid from Cargille Laboratories (Cedar Grove, NJ). 
Twenty-four (3 × 8 column × row) flow cells were used for the experiments described in 
this paper. Streptavidin solutions of eight concentrations (1700.0, 566.7, 188.9, 63.0, 
21.0, 7.0, 2.3, and 0.8 nM) were flowed through the MFCA channels and across the SPR 
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sensing surface at a flow of 33.4 µL/min. The sample volume loaded into each flow cell 
is 300 µL. PBS buffer was loaded in to flow system right after streptavidin solution.  
Daclizumab-IgG Binding Affinity Measurement 
In the same way as studying the biotin-streptavidin interaction, the surface was 
functionalized with SAMs first. Then streptavidin solution of 1.85 µM, biotinylated 
Daclizumab of 0.7 µM was flowed over 24 micro flow cell sequent to make Daclizumab 
surface. Goat anti-human IgG solutions of eight concentrations (500, 167, 55.8, 18.6, 6.2, 
2.1, 0.7, and 0.2 nM)) were flowed over the SPR sensing surface at a flow rate of 133.6 
µL/min. The loading sample volume was 180 µL for each flow channel.  PBS buffer was 
flowed over and washed off unbound IgG on the sensing surface right after the previous 
step. 
Flow Rate Test 
The flow rate effect was examined by running the biotin-streptavidin interaction at 
four flow rates: 33.4, 133.6, 267.2 and 534.4 µL/min, respectively. Streptavidin solutions 
of eight concentrations (1700.0, 566.7, 188.9, 63.0, 21.0, 7.0, 2.3, and 0.8 nM) were 
flowed through the MFCA channels and across the SPR sensing surface. The sample 
volume loaded into each flow cell is 300 µL.  
SAMs Formation for XPS Analysis 
Zero point one mM mixed BAT and OEG solutions with BAT mixed percentage of 0, 
10, 50, 80, and 100 were prepared first. Gold-coated microscope glass slides were 
immersed into each solution for 24 h. Then the substrate was removed from the solution, 
rinsed with pure ethanol, and dried by a stream of nitrogen for XPS analysis.  
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XPS spectra were acquired by Dr. Brian van Denver in the microfab in University of 
Utah using a Kratos Axis Ultra DLD instrument (Chestnut Ridge, NY). XPS survey 
spectra data was collected with a pass energy of 160 e, a step increment of 1 eV and a Al 
Kα source power of 144 W.  
In Situ SAMs Preparation for SPR Analysis 
Gold-coated substrate was mounted on the prism with refractive index matching liquid 
and MFCA was integrated with SPRM. 0.1 mM mixed thiols solution with BAT % in the 
range of 0, 10, 50, 80 and 100% were loaded into 20 flow cells at a flow rate of 33.4 
µL/min. 6 × 4 (column × row) flow cells were used in the test and four flow cells in a 
column were duplicates. Each flow cell is oval shape of size 150 × 200 µm. One column 
was filled with water for the control experiment. After thiol solutions filled the flow cells, 
the flow was stopped for an hour while thiols diffused and adsorbed on surfaces. Then 
100% pure ethanol was flowed over the surface to wash off excess thiols. PBS buffer was 
run through each flow cell before streptavidin adsorption. Zero point one mg/mL 
streptavidin solution was used to test the capture ability of SAMs surfaces with various 
densities of biotin. The whole process was monitored and recorded at a light incident 
angle of 54.25° by SPRM.  
Atomic Force Microscopy (AFM) Analysis of  
SAMs and Streptavidin Surfaces 
One hour after in situ immobilization of SAMs and streptavidin, the glass substrate 
was removed from the prism and prepared for AFM measurement. AFM imaging was 
performed in a ScanAsyst mode with Dimension ICON-PT and Nanoscope Controller 
65 
 
Software (Bruker) in the Surface Analysis Laboratory at University of Utah. The 
ScanAsyst is a tapping mode with automatic image optimization. The scanning 
experiments were carried out in the air at room temperature. The ScanAsyst 
microcantilever was a sharp silicon nitride probe of typical radius of 2 nm. The normal 
spring constant is 0.4 N/m and the resonance frequency is 7 kHz. The scan rate and image 
resolution are one Hz and 512 × 512 pixels, respectively. The images used for roughness 
analyses were corrected with a second-order flatten filter in the Nanoscope software.  
Protein A-IgG Interaction 
 Twenty-four (6 × 4 array) flow cells were used in this experiment. First the surface 
was functionalized with SAMs by immersed into 0.1 mM BAT solution for 24 h. A 
mixture of ethanol and water (Refractive Index 1.3391) was flowed through all 24 flow 
cells to test the change of the SPR signal to bulk refractive index changes. Biotinylated 
protein A solutions of five concentrations (0.66, 1.3, 2.6, 5.3 and 10.6 nM) were flowed 
through the MFCA channels and across the SPR sensing surface at a flow rates of 33.4 
µL/min. Mouse IgG concentration of 1.33 µM was flowed over protein A surface to tests 
their activity. The loading sample volume of protein A and IgG are both 250 µL for each 
flow cell. Binding of mouse IgG and biotin-protein A was monitored at a light incident 
angle of 55.1° by SPRM.  
Results and Discussion 
SPR for biomolecular interaction analysis provides quantitative analysis of binding 
affinity and kinetic data of binding process. The two model systems of (1) biotin-
streptavidin and (2) biotinylated Daclizumab-IgG, represent two types of interactions: 
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 in solution and streptavidin  has been used as a 
molecular linker in many applications in biosensing.
23-25
 In a previous report, we 
demonstrated that the biotin-streptavidin interaction is a robust and efficient strategy to 
immobilize antibodies on an SPR sensing surface.
21
 In order to create a high-density and 
high-activity antibody array, we further studied the interaction of biotin-streptavidin in 
the MFCA to optimize the conditions for antibody immobilization. Daclizumab-IgG 
interaction was used to mimic an immunogenicity assay of Daclizumab to screen anti-
drug antibodies from serum or blood samples. Daclizumab is a humanized antibody drug 
with 90% structure sequence from human IgG, and goat anti-human polyclonal IgG 
worked as pseudo anti-drug antibodies in the binding affinity study. The binding affinity 
and kinetic measurement will provide information to develop immunogenicity assays 
based on the integrated MFCA-SPRM.  
Binding Reactions and Concentrations 
Before the biotin-streptavidin interaction analysis, the gold-coated SPR sensing 
surface was functionalized with biotin-terminated SAMs. Then streptavidin solutions of 
eight concentrations were flowed over 24 flow cells in MFCA at a flow rate of 33.4 
µL/min; each concentration sample was run in three duplicates. The tested streptavidin 
concentration was in the range of 0.8 to 1700 nM and the sample volume was 300 µL for 
each flow cell.  
Figure 3.8a is the real-time SPR signal of streptavidin adsorption collected by using 
the SPR microscope. Each curve represents an average of three duplicates. The detection 
limit of streptavidin was 7.0 nM under experimental conditions. Streptavidin samples of 
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concentrations above 63.3 nM can saturate the surface within a tested time of 10 min.  
When the adsorption reaction reaches equilibrium, the SPR signal can be converted to a 
surface density of streptavidin molecules by using the quantitative method reported in 
Chapter 2.
23









 The lower surface 
density is due to the continuous-flow deposition that can wash off unbound streptavidin 
molecules while the reported one was deposited with microspotting. One thing that needs 
to be pointed out is the shape of the SPR curve for the 63.3 nM sample. The reaction rate 
was slower during the time from 250 to 340 s because the flow was stopped for sample 
loading. The decreased reaction rate shows that the reaction rate is slowed by the flow 
rate for the sample of concentration 63.3 nM. The reaction rate resumed after the flow 
was started again.   
The surface concentration of streptavidin observed at equilibrium versus the bulk 
concentration of streptavidin was fitted into a first-order Langmuir model (equation 3.13) 
in Figure 3.8b. The dissociation constant (KD) calculated from the Langmuir model is 




 = 0.942), which is larger than the reported value (10
-13
 M) in 




 In fact, due to the interaction among the immobilized ligands, the data of binding 
interaction of biotin-streptavidin fitted better with an extended Langmuir model in 





 = 0.98). Equation 3.14 is also described as the Hill-Waud model and n is the Hill 
coefficient of cooperativity.
27
 This model is used to find the best fit and n is found to be 




         
  
     
                                                            
 




    
                                                           
      
With the experimental constants listed in Table 3.4, the biotin-streptavidin interaction 
was modeled and the kinetics of the reaction were plotted in Figure 3.8c. The rate 
constants of kon and koff listed in Table 3.4 were calculated from the value of the 
dissociation constant (            ) and the saturation time (            
       measured from the real-time SPR curves as shown in Figure 3.8a. Comparing the 
surface concentration of binding products at the equilibrium time to the maximum surface 
concentration gives the degree of surface saturation, which is called fractional saturation 
or saturation fraction. A comparison of the fractional saturation from experiments and 
simulation results versus the streptavidin bulk concentration is presented in Figure 3.8d. 
The data points in Figure 3.8d show that for the same streptavidin sample concentration, 
the experimental fractional saturation is larger than the simulated one in all of the 
samples except the highest concentration. One abnormal data point in Figure 3.8d could 
be caused by experimental errors.  The same observation was also found in Daclizumab-
IgG interaction; the result of experiments was summarized in Figure 3.9a and b. Figure 
3.9c was the simulation plot and a comparison of simulation and experimental results 
were presented in Figure 3.9d.  
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A higher fractional saturation indicates a higher reaction rate in the experiments 
compared to the modeling. This discrepancy can be attributed to the limitations of the 
model. Although the modeling has reflected the major physical process in the flow cell, it 
is far from being complete and realistic. First, the 1D model cannot fully describe the 
mass transport on a 3D scale. One possible explanation for a higher reaction rate in the 
experiment is a thinner concentration boundary layer formed in the experiment compared 
to the modeling. The boundary thickness plays a key role in determining the 
concentration gradient, concentration of reactant and diffusion time for analytes from the 
bulk to the reactive surface. The order of magnitude thickness of the concentration 
boundary layer δ is related to the shear rate (γ) as shown in the equation below: 
 






                                                                   
where D is the diffusion constant and l is the lateral length along the reaction surface. The 
shear rate is the rate of change of velocity at which one layer of fluid passes over an 
adjacent layer. In the model, only the shear rate in the direction along the 1D reactive 
surface was considered. While in the experiment, the shear rate on the SPR sensing 
surface changed in two directions, especially in the region that is perpendicular to the 
inlet and outlet microchannels. The higher shear rate leads to more efficient delivery of 
reactants and a higher concentration of reactants, so the reaction rate in a 3D flow cell is 
higher compared to 1D modeling. 
 Another possible reason is the model has an assumption of uniformly distributed and 
evenly active surface binding sites. Heterogeneity of the surface, steric effects, and 
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conformation and activity of immobilized biomolecules and their interactions could all 
cause the differences between experimental and simulated results. For example, the 
cooperative binding on the high-density biotin surface has caused different binding 
affinity and reaction rate.
26
  
  In addition, inaccurate constants being applied in the modeling could also cause may 
lead to different results. For example, values of surface and solution diffusion constants 
were set to be equal in the simulation using reported values.
19
 However, according to the 
Einstein–Stokes equation, the solution diffusion constant depends on the temperature and 
the viscosity of solution. The surface diffusion constant has been reported to depend on 
the surface concentration of adsorbed protein. The dynamic range of the surface diffusion 
constant could be of one order of magnitude.
28
  
Overall, the modeling could be further improved by the selection of proper constants 
and setting of boundary conditions. However, the prediction from the modeling is limited. 
Although the modeling is useful to predict the effect of analyte bulk concentration, 
effects of flow rate and surface density of binding sites are more complex and will be 
further investigated with experiments. 
The Daclizumab-IgG interaction served as a model system for studying 
immunogenicity assay as mentioned before. The immunoasaay following the 
immobilization of SAMs, streptavidin and biotinylated Daclizumab was described in the 
methods section. IgG solutions (180 µL/ channel) of eight concentrations from 0.2 to 500 
nM were flowed over a Daclizumab-functionalized surface at a flow rate of 133.6 
µL/min; each concentration sample had three duplicates. Compared to streptavidin 
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solutions, a lower concentration range of IgG was used because this model system was 
used to investigate the detection limit of the immunoassay.  
The experimental and simulation results were presented in Figure 3.9. Figure 3.9a 
shows the real-time SPR response curves of five detectable samples. The detection limit 
was 18.6 nM under the tested condition. The surface density of IgG was calculated and 





 = 0.988) from the model, which is higher than biotin-streptavidin 
interaction. Cooperative binding is not obvious because the data fits well with a simple 
Langmuir model. A simulation of the interaction usingconstants listed in Table 3.4 is 
presented in Figure 3.9c. The simulated result shows that the reaction rate increases with 
an increased bulk IgG concentration, which is consistent with the experimental results in 
Figure 3.9a. However, when comparing the saturation fraction at equilibrium time in 
Figure 3.9d, all of the experimental results are higher than the simulations due to 
limitations of the modeling as discussed before. 
Effect of Flow Rate  
From the previous theoretical study, the effect of flow rate on the binding kinetics the 
reaction in the MFCA is not significant within the flow rate range controlled by the 
peristaltic pump. However, the discrepancy of experimental and simulation results had 
shown that the effect of flow rate cannot be fully predicted from the simulation. In order 
to investigate the flow rate effect on surface reactions, an experiment was carried out 
with a fixed volume (180 µL) of streptavidin to interact with a biotin-functionalized 
surface at four flow rates, ranging from 33.4 to 534 µL/min.  Streptavidin of eight 
concentrations from 0.8 to 1700 nM were used in the experiment. 
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 SPR curves of biotin-streptavidin interactions at increasing flow rates are shown in 
Figure 3.10. The flow rates increased from top to bottom in the graph. The time scale is 
set to be equal among all four plots for the comparison of signal changes. Obviously, for 
samples of the same concentration, the higher the flow rate, the faster the reaction reaches 
equilibrium. In another words, within a limited reaction time, higher flow rates generate 
higher SPR signals. The same findings were also reported in an ex situ protein deposition 
with the same continuous flow system.
29
  
As discussed before, if the reaction is limited by diffusion, the height of the boundary 
diffusion layer is critical in determining the reaction rate. The height of the diffusion 
layer is inversely proportional to the flow rate as shown in equation 3.12. When the flow 
rate increases in the MFCA, the diffusion layer decreases and the reaction rate increases. 






   
  





                                                                  
where γ is the shear rate and proportional to the flow rate v. So the reaction rate is linear 
with the flow rate to the one-third power. To determine if the reaction in MFCA is 
diffusion  limited, the SPR signal at reaction time t = 20 s is used to represent the reaction 
rate since the SPR signal is linear with the surface concentration of binding products.
23
 
The effect of flow rate on the reaction rate is illustrated in Figure 3.11. The plot shows 
that at low concentrations, the reaction is diffusion-limited at tested flow rates since the 
data fits well into a linear model (R
2
 = 0.98~0.99). However, as the concentration 
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increases, the goodness of fit (R
2
 = 0.88~0.96) falls because the reaction becomes more 
reaction-limited and less diffusion-limited at high flow rates.  
Figure 3.12 presents the equilibrium isotherms of biotin-streptavidin interaction 
measured at four flow rates. The graphs show that the SPR signal at the lowest flow rate 
has the highest response signals. This can be explained by the surface concentration at 
equilibrium depending on the reaction rate times the contact time. As said before, the 
diffusion-limited reaction rate             
 
 ; the contact time is equal to the sample 
volume (Q) divided by the flow rate (Q/v), so for a fixed sample volume, the surface 





, as all the other conditions are the same. Therefore, for a low 
concentration sample in a diffusion-limited reaction, a lower flow rate is preferred to 
generate a higher signal with a limited sample volume, which is important to improve the 
detection limit of assays. 
The data in Figure 3.12 were fitted into an extended Langmuir model (n = 2) and the 
calculated dissociation constants were listed in Table 3.5. The dissociation constants from 
the equilibrium isotherms tested at flow rates above 133.6 µL/min are very close with a 
fixed 180  l/min sample. Because as the flow rate increases, the reaction transits from 
diffusion-limited to reaction-limited, the effect of flow rate becomes trivial. The 
dissociation constant of 33.4 µL/min is slightly lower than others because the reaction is 






Optimization of Biotin-Terminated SAMs Surface 
From the previous study of biotin-streptavidin interactions, the cooperativity shows 
that the surface density of binding sites has an effect on the binding kinetic analysis with 
MFCA-SPRM. SAMs of biotin-terminated thiols on gold surface is important for 
immobilize streptavidin and other biomolecules.  The surface density of biotin on a SAM 
is controlled by varying the mixed ratio of BAT and OEG in solution. The binary thiol 
SAMs for streptavidin immobilization is a well-studied system and has been 
characterized  by many surface analysis techniques, such as XPS, STM and FTIR.
30-33
 
The optimal ratio of BAT/OEG in solution used for experiments is reported to be 
between 0.1 to 0.5 for the maximum the streptavidin adsorption.
30
 To create an optimal 
biotin surface for immobilization of biomolecules using the MFCA, we apply the MFCA-
SPRM for in situ formation of binary SAMs and compare their capacity for streptavidin 
adsorption.  
Thiol solutions prepared with BAT mol% of 0, 10, 50, 80 and 100% were loaded into 
individual micro flow cells and reacted with the gold SPR surface for an hour. After that, 
pure ethanol was flowed over the surface to get rid of unbound molecules; PBS buffer 
was flowed to establish the baseline for SPR analysis of streptavidin adsorption. A 
concentrated streptavidin solution of 0.1 mg/mL was used to test the biotin activity of 
various surface densities.  After the SPR analysis, the SPR substrate was removed from 
the prism and put into an AFM system to map the morphology of streptavidin on the 
surface. XPS was used to quantify the amount of biotin in the SAMs. The XPS sample 
was prepared with gold-coated microscope glass slides immersed into the thiol solutions 
mentioned above for 24 h. 
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Figure 3.13a presents the SPR real-time curves of streptavidin adsorption on SAMs of 
various surface density of biotin. Figure 3.13b shows a summary of the SPR equilibrium 
signals from Figure 3.13a. Non-specific adsorption of streptavidin on 100% OEG surface 
is very low, 0.44 ± 0.13 % reflectivity. Streptavidin adsorption on the surfaces of 10, 50, 
80, and 100% BAT are saturated with little difference in SPR signals, which are 6.58 ± 
1.64, 5.73 ± 0.91, 6.70 ± 1.09, and 7.12 ± 1.82% reflectivity, respectively. Compared to 
previous data of streptavidin adsorption, the relative standard deviation is larger than 
15% because the in situ formation of SAMs causes surface heterogeneity. Although the 




The density of biotin on the surface is proportional to the BAT% in solution and was 
proved by XPS analysis results shown in Figure 3.14. Since the nitrogen N (1s) in XPS 
spectra was only attributed to BAT, we use the ratio of nitrogen N (1s) peak area in 
Figure 3.14a normalized to Au (4f) peak to represent the surface density of biotin. The 
surface density of biotin has a linear relationship with BAT% in solution shown in Figure 
3.14b. Among all the surface density, from 10% to 100%, the capacity for maximum 
streptavidin adsorption does not vary too much. So the lower the surface density is, the 
higher the capture efficiency for biotin-terminated SAMs.  
AFM was applied to characterize the adsorbed streptavidin layer on a SAMs surface 
after SPR analysis. Figures 3.15 and 3.16 are AFM images of SAMs and streptavidin 
surfaces obtained with a tapping mode in the air at room temperature. The RMS 
roughness of all SAMs and streptavidin surfaces were summarized and compared in 
Figure 3.17. The roughness of SAMs is below 2 nm and is about 4 nm for streptavidin 
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surface. The SAMs AFM image shows that the OEG and BAT thiols formed phase-
separated domains because of defects of gold surface and entangling effect of long-chain 
OEG thiols.
35
 Also the domain size and packing conformation of SAMs depend on the 
assembly solution conditions, such as temperature.
32
  These nanoscale structure and 
properties could affect protein adsorption.
36
 Therefore, the surface heterogeneity of 
mixed SAMs surfaces could affect the streptavidin adsorption.  
However, AFM images in Figures 3.15 and 3.16 are dried streptavidin surface after 
SPR analysis. The aggregated streptavidin images could not provide enough information 
of the adsorption affected by the surface density of binding sites and heterogeneity.
32
 But 
the measured roughness number could be used as a rough estimation of the amount of 
streptavidin bound to the surface if protein aggregation does not cause loss on the 
surface. The number shows the amount of streptavidin on surfaces of BAT over 50% are 
close and has reached saturation.  The 10% BAT surface roughness is low which is 
inconsistent with the result of SPR analysis. This could be due to the protein on the 
surface was lost after drying. 
 Overall, mixed thiol solutions with BAT over 10% can be used for preparation of 
SAMs surface for streptavidin adsorption, and increasing the amount of BAT from 50% 
to 100% does not show significant improvement of the maximum adsorption capability of 
SAMs surfaces.  
Surface Density and Activity of Immobilized Protein A  
Protein A is a surface protein (M.W. ~ 42,000 Da) originally found in the cell wall of 
the bacteria Staphylococcus aureus that has specific binding to the Fc region of IgG from 
various animals.
37





 Here we investigated the surface density of immobilized protein A with 
relations to their activity. The experiment was carried out by starting the test of SPR 
response to the bulk refractive index change, which is an experiment designed to test the 
signal variance among microspots. Then streptavidin was immobilized on a biotin-
terminated SAMs surface. Biotinylated protein A solution of various concentrations from 
0.66 to 10.6 nm were loaded into flow cells to create different surface density of binding 
sites and mouse IgG of 1.33 µM was delivered to the protein A surface to test the 
activity. Signal of protin A-IgG interacions will also be used in the analysis of spot-to-
spot signal variations.  
Figure 3.18 shows a plot of SPR real-time curves of the whole experiment process 
with a SPR image of 24 flow cells and their detection windows for the signal collection. 
The SPR signals of protein A and IgG adsorption are summarized and compared in 
Figure 3.19a. The plot shows that the SPR signal of IgG adsorption on all protein 
surfaces are almost on the same level except the lowest one created using a 0.66 nM 
solution. But the SPR signal of protein A adsorption increases with the bulk 
concentration of protein A. By converting the SPR signal to surface density, Figure 3.19b 
is the binding ratio of IgG to protein A on various protein A surfaces, ranging from 1:1 to 
2.8:1. The binding ratio decreases with an increasedecrease in the bulk concentration of 
protein A, which indicatesa lower surface concentration of protein A, the higher capture 
effiency of protein A. It is predicted that each protein A has five binding sites to IgG 
from the sequence study of protein.
39
 However, reported experimental data shows various 






The protein A-IgG interaction demonstrates that the adsorption of IgG on a protein A-
functionalized surface does not increase with the surface concentration of binding sites, 
which is due to the 3D structure of binding sites on microscopic scale not being  
uniformly active and evenly distributed.
40
 The molecular size and orientation of 
immobilized protein, interactions such as steric and electrostatic forces among binding 
sites could cause the local surface heterogeneity and binding activity. Lower surface 
concentration of binding sites leads to higher activity, but higher surface concentration of 
binding sites capture the most absolute amount of analytes as shown in Figure 3.19.  
Spot-to-Spot Signal Variations 
Minimizing spot-to-spot signal variation is important for the MFCA-SPRM to develop 
reliable assays and generate reproducible data. In this part, data from previous 
experiments of protein interactions were used to investigate possible sources that cause 
signal variations among micro flow cells. 
Table 3.5 is the SPR signal of bulk refractive index changes and protein A-IgG 
interactions in Figure 3.18. The positions of data in Table 3.5 correspond to the position 
of flow cells in Figure 3.18. The coefficient of variation (CV) of SPR signal of flow cells 
in a row lies in range of 3.27% to 7.33%, and the CV of SPR signal in a column is from 
0.17% to 4.17%. Table 3.6 is the SPR signal of the adsorption of streptavidin in the same 
24 flow cells. The CV of a row and column are in the range of 9.26% and 14.95%, 2.26% 
and 8.14%, respectively. In both tests, the samples were the same for all 24 flow cells. 
 Generally, the CV in a row is larger than the CV in a column. The larger CV in a row 
is caused by the shift of light incident angle at the back of SPR sensing surface in a hemi-
spherical prism. Shown in Figure 3.19a, the SPR system is based on Kretschmann 
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configuration. Theoretically, collimated light is used to excite surface plasmon in the 
center of a semispherical prism. However, in order to illuminate a large sensing area, the 
size of light beam becomes so large that after the light traveling through the prism and 
being reflected at the back of sensing surface, the light incident angle varies from the 
beam center to both edges. Figure 3.19b shows an example of the shift of light incident 
angle. If the refractive index of prism (n) is 1.80, the diameter of the prism (D) is 8 cm, 
the diameter of light beam (d) is 1 cm, and the light incident angle of beam in the center 
is 55
o
. The light incident angle is 56.3
o
 at the left edge and 53.7
o
 at the right edge, which 
were calculated with Snell’s law. As discussed in Chapter 2, the SPR microscope 
sensitivity factor depends on the light incident angle and is limited within two linear 
ranges.
23
 Both of these two linear regions are less than one degree, so the 1.3 degree shift 
could cause the response at the edges to exceed the linear range.  This is an intrinsic 
property of the prism and could be overcome by using a hemi-spherical prism of larger 
diameter, minimizing the SPR sensing area or changing to a prism of a different shape 
such as a dove prism.  
The overall CV of the streptavidin adsorption signal (12.0%) is larger than bulk 
change (5.36%). This is due to the mass transport and surface heterogeneity introducing 
variation in local refractive changes and corresponding SPR signals.
35
 Major variables 
include variation of flow rate among flow cells, the nanoscale heterogeneity of SAMs 
surface, conformation, binding activity of immobilized proteins and interactions among 
binding sites etc. One possible solution to improve the mass transport is to change the 
geometry of flow cells based on equation 3.12.  
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Next the CVs for streptavidin adsorption using two types of micro flow cells were 
compared. One set of data is in Table 3.7 from protein A-IgG interaction, which was 
collected with flow cells of oval shape (250 × 150 µm). The SPR signals of streptavidin 
are 6.74 ± 0. 81 % reflectivity and the CV is 12.04%. The other set of data was based on 
an MFCA of octagon shape (650 × 400 µm) in Figure 3.21. The SPR signals of 
streptavidin adsorption are 4.20 ± 0. 60 % reflectivity and the CV is 14.30%. So, at least 
in this case, changing the geometry of flow cell does help improve the CV, however, the 
effect is not significant. Overall, the CV among 24 micro flow cells is below 5.36% for 
the test of bulk refractive index and below 15% for protein adsorption with the oval 
shaped MFCA.  
Conclusions 
We used both modeling and experimental methods to investigate factors that impact 
the biomolecular interaction analysis based on MFCA-SPRM. First, we used 2D 
modeling to demonstrate that the bulk concentration of analytes, binding affinity and 
surface density of binding sites are important parameters that determine the reaction rate 
on the sensing surface while the effect of flow rate is trivial from the modeling. 
The biotin-streptavidin and Daclizumab-IgG interactions were used as two model 
systems to optimize the antibody immobilization and improve the detection limit of 
immunoassays. The parameters measured by experiments were applied in the modeling to 
compare the simulation and experimental data. However, the modeling results do not fit 
perfectly with experimental ones because mass transport and reactions in 3D flow cell are 
more complex than the modeling. The discrepancy between the modeling and 
experimental motivates further investigation of the effect of flow rate and surface density 
81 
 
of binding sites with experiments. The flow rate effect was examined by using fixed-
volume of streptavidin that interacted with SAMs surface. The result shows the reaction 
rate in MFCA is proportional to the flow rate. As the flow rate increases, the reaction 
transits from diffusion-limited to reaction-limited. For a diffusion-limited reaction, the 
surface concentration of product changes linearly with time but 1/3 power of flow rate 
with a flow cell of fixed geometry. However, the lowest flow rate generates the highest 
SPR signal because of a long reaction time with the constraint of sample volume.  
Finally, we identified that the major source of spot-to-spot signal variations is from the 
optical system and variables in the mass transport and reaction that introduce the 
heterogeneous local refractive changes. Changing the geometry of the flow cell shows 
improvements but the effect is limited.  
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Figure 3.1. 2D schematic representation of a single micro flow cell in the MFCA-SPRM 
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Figure 3.2. 2D mesh of MFCA modeling region. The length of the reaction surface at the 
bottom is 650 µm; the widths of the inlet and the outlet are 150 µm, and the height in the 
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Figure 3.5. Kinetics of surface binding products simulated by using two sets of binding 
affinity constants and various bulk concentrations of analytes. The parameters are listed 
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Figure 3.6. Kinetics of surface binding products simulated by using two flow rates. (a) 
1.47 × 10
-1 
m/s (534.4 µL/min), (b) 4.6 × 10
-3
m/s  (16.7 µL/min). The bulk concentration 
of analyte ranges between 0.1 nM to 1 µM. The binding affinities are kon and koff   are 1.1 
× 10
4
































































Figure 3.7. Kinetics of the formation of surface binding products simulated by using two 
values of surface density. The values are 1.33 × 10
-8 





concentration of analyte is in the range of 0.11 to 18.5 µM. The dashed lines represent a 




) and the solid lines are for a lower 








































I 7~- - - - - - - - - - - - -
I I --- - - - - - - - - - - -
, .' .. .".-- ... -- - - - - - - - - - -
-- 57· ' ,. 
- - 18.5 
. I . : 
- - 1.9 I / 
- - 0.63 I i ,I ______ - - - - - -
- - 0.21 " t .. ----























Figure 3.8. Results from experiments and simulations of biotin-streptavidin binding 
interactions based on the SPRM-MFCA. (a) Real-time SPR response of streptavidin 
adsorption on a biotin SAM surface measured at flow rate of 33.4 µL/min. (b) 
Equilibrium isotherm of biotin-streptavidin interaction summarized from the SPR curves 
in (a).  (c) Kinetics of streptavidin adsorption calculated by simulation with parameters 
listed in Table 3.4. (d) A comparison of the average fractional saturation of the reaction 
surface measured by SPR and simulations when streptavidin adsorption reached 
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Figure 3.9. Results from experiments and simulations of Dac-IgG binding interaction 
based on the SPRM-MFCA. (a) Real-time SPR response of IgG adsorption on a 
Daclizumab surface at a flow rate of 133.6 µL/min. (b) Equilibrium isotherm of Dac-IgG 
interaction summarized from the SPR curves in (a).  (c) Kinetics of IgG adsorption 
calculated by simulation with parameters listed in Table 3.4. (d) A comparison of the 
fractional saturation of reaction surface measured by SPR and simulations when IgG 
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Figure 3.10. SPR real-time curves of various biotin-streptavidin interactions. Six 
streptavidin concentrations of 7.0, 21.1, 63.3, 190, 567 and 1700 nM  were tested at four 
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Figure 3.11. SPR signal of biotin-streptavidin interaction at reaction time t = 20 s versus 
the flow rate to the one-third power. The data were fitted into a straight line for 










































Figure 3.12. Equilibrium isotherms of biotin-streptavidin interactions at flow rates of 
33.4, 133.6, 267.2 and 534.4 µL/min. The solid lines are fits of the data using an 
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Figure 3.13. Experimental results of streptavidin adsorption on various SAMs surfaces of 
in situ functionalized by the SPRM-MFCA. (a) Real-time SPR response of streptavidin 
adsorption on a Daclizumab surface at a flow rate of 16.7 µL/min. (b) The SPR signal of 
streptavidin adsorption versus BAT percentage in thiol solutions used in the 
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Figure 3.14. XPS spectra of the N (1s) region for all of the mixed SAM surfaces. (a) XPS 
spectra of the N (1s) region for all of the mixed SAM surfaces. (b) The peak area ratios of 
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Figure 3.15. AFM images of gold surface deposited by electron-beam deposition and 
functionalized SAMs surfaces. (a) gold surface (b) SAMs surface deposited by 100% 
OEG. (c) SAMs surface deposited by 50% OEG and 50% BAT. (d) SAMs surface 
deposited by 100% BAT. The RMS roughness of (a)-(d) surfaces are 1.38, 1.43, 1.61 and 

































Figure 3.16. AFM morphology images streptavidin adsorbed on various SAMs surfaces. 
(a) SA on SAMs surface made by thiol solution of 10% BAT. (b) SA on SAMs surface 
made by thiol solution of 50% BAT. (c) SA on SAMs surface made by thiol solution of 
90% BAT. (d) SA on SAMs surface made by thiol solution of 100% BAT. The RMS 








































Figure 3.17. Results from AFM analysis of RMS roughness of SAMs surfaces and 
streptavidin surfaces on corresponding SAMs.  The yellow bar represents surface 


































































Figure 3.18. Results from experiments of protein A- IgG binding interaction based on the 
SPRM-MFCA. (a) SPR image of 24 flow cells filled with solutions (b) SPR real-time 
curves of the process of bulk refractive index change, streptavidin, protein A and IgG 
immobilization.  Concentrations of five protein A solutions are 0.66, 1.3, 2.6, 5.3 and 
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Figure 3.19. SPR signals of IgG adsorption on protein A surface and signal ratios. (a) 
SPR response signal of IgG adsorption on protein A surface and the corresponding SPR 
signal of protein A adsorption.  (b) Binding ratio of IgG/protein A versus the bulk 
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Figure 3.20. Schematic of the light path in the SPRM and the shift of light incident 
angles. (a) Schematic of the light path in the SPRM system. (b) Shift of light incident 
angles at the back of SPR sensing surface after light traveling through the hemi-spherical 
prism. For example, if the refractive index of prism (n) is 1.80, the diameter of the prism 
(D) is 8 cm, the diameter of light beam (d) is 1 cm, and the light incident angle of beam 
in the center is 55
o
, the angles of 1-7 in the figure are calculated to be 7.5, 3.72, 11.22, 
6.2, 53.7, 47.5, and 56.3
o
, respectively. The light incident angle at the left edge of the 
beam is 56.3
o





















































Figure 3.21. Results from experiments of streptavidin and Daclizumab adsorption in 24 
flow cells of MFCA. (a) SPR image of 24 flow cells and their detection windows. (b) 
SPR real-time curves of the process of streptavidin and Daclizuamb immobilization.  The 



















































Table 3.1. Parameters used in the modeling to investigate the effect of binding affinity 
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Table 3.3. Parameters used in the modeling to investigate the effect of surface density of 




















































































Parameter  unit Bio-SA Dac-IgG 






forward rate constant kon m
3/ mol•s) 28 17 























































Table 3.5. Dissociation constants of biotin-streptavidin interactions at four flow rates 
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Table 3.6. SPR signal of 24 flow cells to the bulk refractive index change caused by a 


















             
    
 
I 2 3 4 , 6 AVR SID RSD 
A 8.3 7 8.54 9.07 8.41 8.53 8.89 8.63 0.28 3.2W. 
B 8.45 8.65 8.53 9.20 9.29 9.00 8.85 0.36 4.03-;. 
C 7.84 8.72 8.70 9.35 9.51 8.92 8.84 0.59 6.70-/. 
D 7.79 7.94 8.77 9.05 9.32 9.03 8.65 0.63 7.33% 
AVR 8.11 8.46 8.77 9.00 9.16 8.96 
STO 0.35 0.36 0.23 0.42 0.43 0.06 






































2 3 4 , 6 AVR SID RSD 
A 5.63 5.82 6.96 6.31 7.01 7.79 6.59 0.82 12.39% 
B 6.10 6.34 6.84 7.71 7.27 7.50 6.96 0.64 9. 26¥. 
C 5.45 6. 19 6.45 7.13 7.57 7.92 6.78 0.92 13.6W. 
D 5.26 5.74 6. 52 7.05 7.46 7.81 6.64 0.99 14.95% 
AVR 5.61 6.02 6.69 7.05 7.33 7.75 6.74 0.81 
STO 0.36 0.29 0.25 0 . .57 0.24 0.18 
RSD 6.45% 4.79% 3.67% 8.14% 3.31% 2.26% 
CHAPTER 4 
INVESTIGATION OF THE MFCA-SPRM SYSTEM FOR 




A preliminary investigation of developing an immunogenicity assay for patients who 
undergo treatment with the antibody-based therapeutic Daclizumab with the MFCA-
SPRM system is presented in this chapter. Daclizumab is a humanized monoclonal 
antibody drug that is currently being investigated in a phase II clinical trial as a 
therapeutic for patients with relapsing-remitting multiple sclerosis.
1
 Previously, 
Daclizumab was developed as an immunosuppressant in organ transplantations.
2
 The 
biological target of Daclizumab is the interleukin-2 receptor (IL-2R) alpha unit of T 
cells.
2
 IL-2R is a heterotrimeric cytokine receptor
3
 involved in T cell activation and often 
serves as a drug target in immunologic therapy.
4
 The mechanism of the biological effect 
of Daclizumab is to bind to IL-2R and prevent T cell activation and further formation of 
antibodies produced against the transplant. 
Multiple sclerosis is an autoimmune disease in which active immune cells attack the 





it suppresses the activity of the immune system.
1
 However, because of the complexity of 
the human immune system, when biological drugs such as Daclizumab enter the human 
body, these therapeutics could be accepted as self-molecules by the immune system or 
lead to a specific or nonspecific immune response.
5
 The ability of biological drugs to 
induce an immune response is called immunogenicity. Characterization of 
immunogenicity is an important aspect of drug development.
4-6
 Especially, unwanted 
immunogenicity is a big concern in clinical trials due to the potential safety and efficacy 
issues,
6-8
 although there have been significant improvements in understanding and 
reducing immunogenicity during the initial of drug design process.
9-11
 
Typically the first approach in assessing immunogenicity is the detection, 
measurement and characterization of anti-drug antibodies (ADAs) from patient serum 
samples.
12
 Recommendations for the design, optimization and validation of 
immunoassays for detection of ADA have been made by members of the American 
Association of Pharmaceutical Sciences.
5, 13
 However, information provided by a single 
analytical method usually is incomplete, and an array of methods is recommended for 
accurate evaluation of immunogenicity of a biological drug. 
The available bioanalytical methods include radio-labeling, enzymatic, fluorescence, 
electrochemical luminescence detection and SPR with various assay formats, such as 
direct, indirect, bridging and competitive assays. Compared to all of the other labeled 
methods, SPR is a label-free, real-time and quantitative method for direct screening of 
ADAs from serum samples with minimal sample preparation. Label-free detection of 





Because 90% of the Daclizumab structure sequence is from human IgG, the similar 
structure characterization cause it hard to find chemical label agents for specific binding 
and detection of ADA.  
Due to the lack of labeling agent, label-free immunogenicity assays based on the 
Biacore, a commercial SPR system, has been developed. The advantages of 
disadvantages of immunogenicity assay based on Biacore include the low-throughput, 
nonspecific adsorption, and lower sensitivity when compared to an enzyme-linked 
immunosorbent assay (ELISA). In this chapter, I will investigate use of the integrated 
MFCA-SPRM system to overcome these drawbacks. The MFCA-SPRM system has 
increased throughput and will be efficient in developing screening assays. With proper 
immobilization strategies, nonspecific adsorption could be minimized,
14
 or if necessary 
accounted for with control channels. The capability of MFCA-SPRM for in situ 
microarray fabrication and analysis could preserve the activity of immobilized 
biomolecules and improve the assay sensitivity, as demonstrated in Chapter 3. The 
attempted combination of SPRM with MALDI mass spectrometry in Chapter 5 will 
provide the potential to identify ADAs bound on SPR substrate after SPR analysis in a 
microarray format.  
Experimental  
Materials 
Serum samples from healthy humans were provided by Atlanta Biologicals for control 
experiments to measure non-specific adsorption of serum matrix that could cause SPR 





were provided by Professor John Rose (Department of Neurology, University of Utah). 
Samples were labeled as 83795 (6-year treatment), 78817 (4-year treatment) and 83414 
(no treatment) were selected for a preliminary assessment of the immune response related 
to different treatment times. One hundred µL of each sample were stored at -20 °C before 
being used for the SPR experiments.   
Dilution of Serum Samples 
The biotinylated-Daclizumab microarray was fabricated using the MFCA-SPRM to 
capture ADAs from serum samples. In each micro flow cell, 100 µL streptavidin (40 
µg/mL) and biotinylated-Daclizumab (250 µg/mL) were flowed over biotin-terminated 
SAMs surface continuously. In order to get rid of the signal interference from substances 
other than ADAs, normal human serum samples were diluted to find the optimal dilution 
ratio, because dilution of whole serum samples not only minimized the interference but 
also lowered the concentration of ADAs for detection. PBS buffer (pH 7.4) was used to 
dilute serum samples to 1, 5, 10, 25 and 50%. Four percent bovine serum albumin (BSA) 
and 100 µg/mL Daclizumab were also analyzed in the control experiments of measuring 
nonspecific adsorption. One hundred fifty µL of each sample were loaded into 24 
channels (3 × 8), flowed over a biotinylated-Daclizumab surface at a flow rate of 33.4 
µL/min.  
Screening Assay of Serum Samples 
From last optimization experiments, the optimal dilution ratio was found to be 25% 





hundred µL of each patient serum sample was diluted to 25% with PBS buffer. Four 
hundred µL of each patient sample was delivered into three micro flow cells at a flow 
rate of 16.7 µL/min. A biotinylated-Daclizumab antibody microarray was fabricated in 
the same approach as described above.  After the serum samples were flowed through the 
MFCA and across the sensor surface, PBS buffer was used to rinse the surface.   
Results and Discussion 
Human serum consists of heterogeneous biological components, such as proteins, 
antibodies, hormones and drugs,
15
 which cause potential interferences of ADA detection 
via specific or nonspecific binding. In the SPR screening experiment of Daclizumab, 
factors that affect the ADA assay results  could include the physicochemical adsorption 
of various proteins other than ADA on the SPR sensing surface, the concentration of 
soluble Daclizumab, the presence of drug target (IL-2R), and the possibility of binding 
pairs of Daclizumab – ADA and Daclizumab – IL-2R in the serum samples.  
In order to minimize non-specific adsorption from the sample matrix, dilution of 
serum samples is one easy and fast sample preparation method to lower the concentration 
of matrix.
16
 However, the concentration of detectable ADAs also will be lowered by the 
dilution. Therefore, an optimal dilution ratio was needed. On the ADA capturing surface, 
nonspecific adsorption of 1, 5, 10, 25, 50 % diluted and 100% serum samples from 
normal human, 4% BSA and 100 µg/mL Daclizumab were tested in a microarray format 
and the real-time SPR curves were plotted in Figure 4.1a. The SPR curves show that the 
bulk refractive index of concentrated serum can produce a high SPR signal of 11% 





samples were flowed over the SPR sensing surface, PBS buffer was flowed over the 
surface until the SPR signal indicated that equilibrium had been reached. From the real-
time SPR curves in Figure 4.1a, the average of data after 300 s minus the average of data 
from the initial 50 s is the signal generated by nonspecific adsorption of serum matrix. 
Figure 4.1b shows the plot of the SPR response signal as for different serum dilutions. 
The average SPR signal drops dramatically from 0.9 % reflectivity to 0.3% reflectivity 
when the pure serum sample is diluted to 25%. However, the SPR signals generated by 
the serum samples of concentration equal or less than 25% reach a stable level of 0.33 ± 
0.20 % reflectivity. The 25% dilution sample shows minimal nonspecific adsorption 
while not diluting the ADAs too much, so it was selected as an optimal dilution ratio for 
future sample preparation. Although 25% also was used in reported studies of  the 
immunogenicity of other antibody drugs with SPR,
16
 the data from our investigation 
confirmed the optimal dilution ratio. 
Three labeled serum samples were provided by Dr. John Rose for preliminary 
development of immunogenicity assays for Daclizumab.  One sample (No. 83414) is 
from a multiple sclerosis patient who was not treated with Daclizumab, and two other 
samples were from patients who have Daclizumab treatment for 4 (No. 78817) and 6 
years (No. 83795), respectively. A patient serum sample obtained from patients who did 
not undergo treatment is required as a negative control used in ADA detection because 
SPR detection cannot distinguish directly between ADAs and nonspecific adsorption on 
the surface. These samples were diluted to 25% and flowed over the Daclizumab surface. 





ADA are plotted in Figure 4.2a. A summary of the observed SPR signals is presented in 
Figure 4.2b, which shows that the SPR response signal decreases with the treatment time 
of Daclizumab. The negative control sample (No. 83414) shows the highest SPR 
response of 0.86 ± 0.11 % reflectivity which exceeds the nonspecific adsorption response 
of 0.33 ± 0.20 % reflectivity. The sample from the patient after a 4-year treatment of 
Daclizumab shows a response of 0.49 ± 0.15 % reflectivity, which is as much as 1.5 
times of the nonspecific adsorption. The sample from the patient after a 6-year treatment 
of Daclizumab shows the lowest response of 0.33 ± 0.23 % reflectivity which is close to 
the signal generated by nonspecific adsorption.  
In brief, the immunogenicity of Daclizumab from the SPR result shows that the 
negative control sample gives the highest SPR signal. The differences in the immune 
responses of individual patients as well as the matrix interferences impact the assay 
sensitivity and specificity. In clinical study, the patients’ immune response to a biological 
drug depends on the characteristics of drug and its usage, the disease and the physical 
condition of the individual patient. Bioanalytical assay is only one of many approaches to 
evaluate the immunogenicity of biological drugs. The limitation of immunogenicity assay 
is associated with the methods to detect ADAs and patient immune response. In the SPR 
assay of Daclizumab, the free Daclizumab in serum could bind to soluble drug target of 
IL-2R or ADAs, which may interfere with the detection of ADAs and lead to a false-
negative result. Further investigation could monitor the concentration of free drug and 





It would also be interesting to investigate why the negative control sample (No. 83414) 
shows an SPR signal higher than the nonspecific adsorption. The high SPR signal could 
be due to adsorption of soluble drug target (IL-2Rα) or other proteins in patients’ 
serum.
17, 18
 Analytical methods such as mass spectrometry can be combined with SPR to 
identify molecules bound on the Dacliaumab surface after SPR analysis, which provides 
qualitative and quantitative analysis of ADA. In the future, more samples are required for 
analyses to generate statistically significant data to evaluate the immunogenicity of 
Daclizumab.  
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Figure 4.1. Nonspecific adsorption of serum matrix on biotinlayted-Daclizumab surface 
measured by SPRM-MFCA. (a) SPR real-time curves of samples of diluted serum, 4% 
BSA and 100 µg/mL Daclizumab flowed through 24 micro flow cells, the legends show 
the percentage of serum in samples and curves of same color are replicates. (b) The 
adsorption SPRM signal of diluted serum samples versus dilution percentage. Each data 
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Figure 4.2. ADA binding assay using the SPRM-MFCA to screen ADA from samples of 
three multiple sclerosis patients treated with Daclizumab for different time periods. (a) 
SPR real-time curves of serum samples, labeled as number 83414, 78817 and 83795, 
from patients treated with Daclizumab for 0, 4 and 6 years, respectively. (b) The SPRM 
signal of patient serum samples versus the treatment time. Each data point is from an 
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CHAPTER 5 
USING MALDI MS TO IDENTIFY CAPTURED PROTEINS 
ON THE SURFACE OF ANTIBODY MICROARRAYS 
Introduction 
This chapter describes a versatile method to use the MFCA to fabricate an antibody 
microarray and then identify surface-bound antibodies with a commercial matrix-assisted 
laser desorption/ionization (MALDI) mass spectrometry (MS). The process developed to 
create the microarrays and then use MALDI-TOF MS to analyze these microarrays will 
be useful for future work of combining the integrated MFCA-SPRM with MALDI MS 
for protein analysis. These experiments also demonstrate the capability of using the 
MFCA for fabrication of protein microarrays that may be used for MALDI MS analysis. 
The primary motivation to combine SPR and MALDI MS is to identify surface bound 
proteins after SPR analysis of biomolecular interactions in a microarray format. As 
demonstrated in previous chapters, the integrated MFCA-SPRM system is useful for 
kinetic analysis of protein interactions and quantifying the surface coverage of an 
adsorbed protein layer. However, SPR analysis cannot identify the adsorbed molecules
or perform structure analysis. MALDI MS is a sensitive technique to identify molecules 
on the surface via molecular weight and fragment patterns. As a result, a combination of 
these two techniques will provide both qualitative and quantitative information of protein 
interactions.  
156 
Basically, there are two approaches to combine SPR and MS analysis. One is to wash 
off the surface-bound materials in an elution step and then analyze the desorbed proteins 
present in the wash solution with various MS methods such as MALDI, electrospray 
ionization mass spectrometry (ESI-MS) or liquid chromatography-mass spectrometry 
(LC-MS).
1, 2
 There are some drawbacks of the elution approach, such as time of analysis, 
loss of materials and contamination. The other approach is to use MALDI MS to directly 
analyze the protein bound on the SPR chip, and both SPR and MS analysis are performed 
on the same chip.  This entire on-a-chip method overcomes the drawbacks of the elution 
step.
1-9
 The MFCA can be used for both approaches but we focused on the on-a-chip 
method in this chapter. 
Since 1997, there have been several reports on the combination of commercial, non-
imaging SPR spectroscopy and MALDI MS for on-chip biomolecular analysis.
3-9
 Most of 
these early SPR instruments 
 







 have introduced  some commercially 
available SPR imaging (SPRi) systems. These SPR imaging systems can be applied for 
microarray-based analysis. The microarray can also be analyzed with MALDI MS, and 
the combination of SPRi with MALDI MS can provide a high-throughput platform for 
multiplex protein analysis. 
Previous chapters have described the application of the MFCA-SPRM system for in 
situ microarray fabrication and analysis. Combination of MFCA-SPRM and MALDI MS 
would provide both qualitative and quantitative analysis of protein interactions, which 
would be especially useful to develop immunogenicity assays. The SPR system will 
screen anti-drug antibodies from complex biological samples and captured proteins on a 
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SPR sensing surface will be further identified with MALDI MS. The combination of the 
MFCA-SPRM with a commercial MALDI MS was explored and the result is presented in 
this chapter.  
One technical problem encountered for the combination of SPR and MS was the 
substrate used in the SPR system did not match the thickness requirement in for the 
MALDI instrument.  The glass substrate used in for SPRM is 2 mm thick but the normal 
sample thickness for MALDI is less than 0.5 mm. Because of this, we used a microscope 
cover glass with a thickness of less than 0.2 mm to replace the SPR substrate for MALDI 
MS. Although the substrate requirement makes it impossible to perform SPR and MS 
analyses on one chip, using the MFCA for SPR analysis and following the same 
procedure to create a microarray for MALDI MS can still provide useful information on 
protein interactions.  
The antibody-antibody interaction was used as a model system to mimic an 
immunogenicity assay. As described before, the gold-coated surface was functionalized 
with biotin-terminated thiols first, and streptavidin was deposited on the SAM surface 
with the MFCA. The first biotinylated antibody was immobilized on the streptavidin 
surface via biotin-streptavidin interaction, and then the second antibody was captured to 
the first antibody surface. The protein microarray fabricated using the MFCA was 
transferred to MADLI MS for molecular identification. A method was developed to 






Micro cover glasses (22 × 22 mm, 0.16 to 0.19 mm thickness) were purchased from 
VWR (Product # 48366067). Biotinylated goat anti-human IgG (Product # AP112B), 
polyclonal human IgG (Product # AG711) and streptavidin (Product # SA101) were 
purchased from Millipore. Sinapinic acid (3,5-dimethoxy-4-hydroxycinnamic acid) (10 
mg/mL) (Product # 186002332) was purchased from Waters Corporation. Conductive 
double-sided adhesive sheets (Product # 05071-AB) were purchased from SPI Supplies.  
Substrate Preparation 
Micro cover glasses were coated with 2 nm Ti and 50 nm Au using an electron-beam 
deposition system as described in Chapter 2. Then the gold-coated glass was immersed in 
1 mM mixed BAT and OEG thiol (mole ratio 1:9) solution for 24 h. Finally, the SAM-
functionalized surface was washed with ethanol and dried with nitrogen.  
Protein Microarray Fabrication 
Twenty four micro flow cells (3 row × 8 column) in MFCA were used to create a 
microarray. Samples in a column were replicates.  Table 5.1 shows the position of flow 
cells and different proteins immobilized in eachlayer. The streptavidin concentration was 
0.1 mg/mL and antibody solutions concentrationswere 0.4 mg/mL. The flow rate was 
33.4 µL/min and the sample volume was 330 µL per flow cell for the entire experiment. 
After each protein deposition step, PBS buffer was flowed over the protein surface to 
wash off nonspecific bound protein. 
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MALDI MS Sample Preparation 
Sinapinic acid (10 mg/mL) prepared in 50/50 (v/v) water/acetonitrile with 0.1% TFA 
was used as a MALDI matrix. Two methods were used to mix protein samples on the 
surface with the matrix.  One method was to apply the matrix to the protein microarray 
surface as a thin mist via an aerosol-spraying device. In the other one, 1 µL of matrix 
solution was added on top of the entire microarray surface, and the solution was allowed 
to dry, leading to crystalline matrix formation.  
MALDI TOF MS 
The MALDI MS experiments were done with help from Dr. James Muller in the MS 
lab in the Chemistry Department in the University of Utah. The prepared microarray 
substrate was mounted on a MALDI target holder (Product # 86002324) with double-
sided tape at a specific position for laser scanning and placed into a Waters micromass 
MALDI micro MX mass spectrometer. The MALDI mass spectrometer was equipped 
with a nitrogen laser (337 nm) operating at 10 Hz. The data were acquired at an 
accelerating potential of 12 kV in the positive and linear modes. A camera was used to 
locate the sample and laser firing positions. Standard instrument software MassLynx was 
used to acquire and analyze the mass spectra. Depending on the surface concentration of 
the protein sample, various numbers of shots (10 to 250) were acquired from the surface 
and the average data is presented as a single averaged spectrum.  
MALDI MS Analysis of Protein Microarray and Sample Standards 
First, a droplet of 100 µg/mL streptavidin solution was added on the gold surface and 
dried at room temperature. Then, 1 µL of sinapinic acid was added to the protein spot and 
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dried in air at room temperature. The same protocols were applied to the other antibody 
standard solutions. The streptavidin sample was used to optimize the instrument settings 
and worked as a standard to calibrate the system. 
Results and Discussion 
Sample Preparation for MALDI MS Analysis 
In order to use MALDI MS analysis, a sample preparation method must be developed 
to mix the protein with MALDI-matrix on the surface. Sinapinic acid was selected as the 
matrix for protein ionization.
13
 At first, an aerosol-spraying was used to paint a layer of 
the matrix on the protein surface. However, it was hard to control the amount of matrix 
sprayed on the surface, so samples prepared by this method did not produce reproducible 
results. Then the standard ‘dried droplet’ method in MALDI sample preparation was used, 
in which 1 µL matrix solution was added onto the sample surface and dried in air or with 
a flow of air. We did not use the standard method for the initial experiments due to a 
concern that the whole microarray pattern would be covered by a single droplet and each 
spot would not be visible. However, it was found that with the dried-droplet method, the 
microarray pattern still visible.  Non-homogeneous matrix film distributed across the 
microarray surface because the surface tension inside and outside microspots were 
different. With the camera in the instrument, it was possible to locate the target sample 
spot and area for laser desorption.  
MALDI MS Detection of Streptavidin Using the MFCA 
Streptavidin is a model protein that has been well studied in applying MALDI and ESI 
MS for noncovalently bound protein complex analysis.
14, 15
 It has a tetramer structure 
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with a molecular weight of approximate 52,800 Da.
16, 17
 A droplet of 1 µL standard 
streptavidin solution (100 ug/mL) was added to the gold surface and formed a thin layer. 
Then a droplet of 1 µL sinapinic acid was added onto the protein layer as matrix for 
analysis. The gold-coated glass with streptavidin was affixed to a MALDI substrate by a 
conductive double-sided adhesive tape and loaded into the MS system. 
The MALDI TOF MS spectrum of streptavidin is shown in Figure 5.1. Major ion 
peaks of m/z at 13104.0, 26221.3, 6576.9 and 39342.3 are labeled in the spectrum. The 
strongest peak (m/z = 13104.0) is from the streptavidin subunit and the peak of the 
streptavidin tetramer (m/z = 52351.8) is weak. The high intensity of the subunit is caused 
by a ‘first-shot phenomenon’ in which the data of intact protein complex can only be 
collected from the first laser shot.
18
 The mechanism is based on when the protein co-
crystalizes with the matrix, the large complex protein segregates to the exterior of the 
crystal and the dissociated proteins remain in the crystal interior. As the laser ablates the 
intact protein near the surface, more subunits were ionized and generated a higher signal.  
The streptavidin was used as a standard to adjust the MS system before each sample 
was run. The MS spectra of the same streptavidin sample collected by the same MALDI 
TOF MS were not consistent from day-to-day experiments. For example, the m/z of 
streptavidin subunit peak could shift from 13115.5 to 13428.0.  The variation of signal 
could be attributed to many factors; the major source of variation could be understood 
from the principles of TOF MS detection. Basically, in a TOF system, ionized molecules 
with charge were accelerated in a potential field and traveled freely before arriving atthe 
detector. The signal of m/z is proportional to the traveling time and the initial energy of 
molecules gained before traveling in a system with fixed traveling length.  The initial 
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energy that molecules gained can be affected by factors that can impact desorption and 
ionization process, such as surface position in the gradient electric field and velocity of 
molecules extracted from their desorption plume. Therefore, the m/z peaks of the same 
ions vary and could not be used as the only standard to identify the protein; fragment ions 
and fragmentation pattern will also be used to identify antibodies captured on surfaces.  
Identify Surface Bound Protein on an Antibody Microarray 
After detection of streptavidin standard on the substrate, the same sample preparation 
approach was applied to an antibody array. The antibody microarray was prepared using 
the MFCA. Three types of protein spots were created on the SAM surface: The order of 
the protein surface layers and their positions on the microarray are shown in Table 5.1.  
The protein microarray was made using the MFCA under continuous flow. After each 
step of protein deposition, PBS buffer was introduced to rinse the excess unbound protein 
away. A big difference between protein deposited by MFCA and the dried-droplet 
method is specific and nonspecific binding, which could affect the surface density and 
homogeneity of protein surfaces. Antibody I and II solutions were also spotted on the 
microarray surface with the dried–droplet method to act as standards to compare with 
spectra acquired from spots.   
  Figures 5.2 and 5.3 are spectra of antibody I and II and act as standards for 
microarray protein identification. The characteristic peaks of antibody I are m/z at 
33532.0, 66844.9 and 86062.7 and they are major signals generated from the subunit of 
the biotinylated antibody I. The whole antibody peak m/z at 160422.9 is weak and hardly 
can be seen from the spectrum.  In Figure 5.3, the characteristic peaks of antibody II are 
m/z at 23685.2, 74849.4 and 149056.1.  Differently from antibody I, the intact antibody 
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peak is higher compared to antibody I, which could be due to the fact that the 
concentration of antibody II standard is higher than that of antibody I from the S/N in the 
spectrum.  
   Proteins on microspots were analyzed and the results are shown in Figures 5.4 and 
5.5. Microspots with a single layer of streptavidin deposited by MFCA could not be 
detected by MALDI MS used in this study. The reason could be the amount of 
streptavidin was out of the detection limit of the MS system. Another reason could be the 
heterogeneous streptavidin surface. The protein aggregated after being dried on surface, 
which is shown by the AFM images in Chapter 3. Surface heterogeneity is a problem in 




Figure 5.4 is the MS spectrum collected from microspots containing three protein 
layers as shown in Table 5.1.  The spectrum has characteristic peaks of both antibodies. 
The peaks at m/z of 23695.2, 75209.0 and 149604.2 are close to the characteristic peaks 
of antibody II and they are of higher intensity compared to those of antibody I of m/z at 
33808.4, 67209.0 and 86537.9. All the characteristics peaks in Figure 5.5 shift to higher 
m/z compared to their standards. But the range of m/z shift (10.0 ~ 600) is not large 
compared to the signal (0.5%), and within the order of signal shift (Δ m/z ~313.0) seen 
from the streptavidin calibration. The reason could be the protein surfaces were prepared 
in different ways and surface concentrations are different.  
 Figure 5.5 presents a MS spectrum from spots with streptavidin and antibody I. The 
spectrum was collected by an average of 223 laser shots across multiple microspots and 
the S/N ratio was very low. The low intensity peaks which can be seen are m/z at 66890.3 
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and 86079.8, which are matched well with antibody I characteristic peaks. Optimization 
of the surface and improvement of the detection limit of MALDI MS method is a goal of 
future work.  
Conclusions 
Overall, a preliminary investigation of using the MFCA to prepare an antibody 
microarray and analyze the surface bound protein with a MALDI TOF MS was 
summarized in this chapter. The investigation shows that the absolute amount of protein 
in microspots is an important factor to determine the MALDI MS detection limit of 
antibody microarray prepared by MFCA. Further optimization of protocols for surface 
sample preparation is important to improve the detection limit of MALDI MS. 
In order to develop a more accurate method to identify proteins, protein digestion on 
chip and tandem MS analyzers can be adopted in the future. This preliminary work also 
demonstrated the possibility of combing the MFCA-SPRM with MALDI MS for high-
throughput, quantitative and qualitative analysis. MFCA can also be applied as a 
microspotter to fabricate various microarrays for MALDI MS analysis. One possible 
future work is to introduce nanoparticles into the combined SPR-MS system; the 
nanoparticles will not only enhance the SPR signal in interaction analysis, but also could 
work as matrix in a MALDI analysis.  
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Figure 5.1. MALDI TOF MS spectrum of streptavidin on a gold surface prepared by 
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Figure 5.2. MALDI TOF MS spectrum of biotinylated antibody I prepared with the 


































66844.9 [Ab1] + 
114977.8 131962.5 151288.7160422.9 
I ' I ' I I I ' , I , mk 























Figure 5.3. MALDI TOF MS spectrum of antibody II prepared with the standard dried-











































































Figure 5.4. MALDI TOF MS spectrum collected from microspots with three layers of 
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Figure 5.5. MALDI TOF MS spectrum of microspots with protein layers of streptavidin 
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 CHAPTER 6 
MFCA-SPRM FOR CHARACTERIZATION OF VESICLE 
IMMOBILIZATION ON PLANAR SOLID SURFACES 
Introduction 
This chapter presents the application of the integrated MFCA-SPRM system in the 
study of vesicle adsorption on planar solid surfaces. The focus of the investigations is to 
characterize effects of vesicle preparation methods, vesicle composition, and the 
hydrophilicity of the binding surfaces on the structure of vesicles immobilized on a SPR 
sensing surface. A simple model to calculate the surface area of a lipid bilayer is 
proposed to correlate the SPR response with vesicle structure on the surface. 
A vesicle is a useful model system of a cell membrane for basic research on the 
structure or function properties of cell membrane components such as receptor 
proteins.
1, 2
 In addition to fundamental molecular biology studies, vesicles also are useful 





on the application, vesicles can be immobilized intact or can form a bilayer on a sensing 
surface, which is a crucial step for using the surface later for molecule recognition.
7, 8
 
Typically, when vesicles adsorb on a hydrophilic solid surface  a process of adhesion, 
flattening, rupture and formation of a planar single bilayer occurs.
9
 Immobilization of 







Because of the fragile structure of vesicles, it is challenging to directly detect and 
measure the surface-bound vesicles. Some techniques have been used or combined to 
characterize vesicles on various surfaces via surface roughness, changes of mass or 
refractive index and fluorescence labeling,
10, 11












 electrochemical impedance measurement,
25
 and 
fluorescence microcopy and spectroscopy
5, 26
 are among the widely used analytical 
techniques.  
Several factors such as the vesicle size (depending on the preparation method),
26
 the 
vesicle composition (lipid- and membrane-bound molecules),
27
 substrate surface 
properties (hydrophilic or hydrophobic, flat or patterned)
28





 play key roles in influencing the adsorption mechanism of 
vesicles on a solid surface. These factors contribute to the interfacial force or surface 
tension that determines the shape or the form of vesicles on the surface.  
The MFCA-SPRM with the closed flow system (no exposure of vesicles to air) is 
useful for high-throughput analysis of immobilization of vesicles and the factors 
impacting this process in a controlled manner. Previously, SPR has been used to analyze 
the interactions between immobilized vesicles and membrane-bound proteins.
5
 In this 
example, the vesicles were composed of a mixture of DOPC and biotin-DOPE and 
immobilized on a streptavidin-coated surface. It is not clear that the vesicles bind to the 
streptavidin surface via biotin-streptavidin interactions or physical adsorption. In order to 
understand the process of vesicle immobilization, the MFCA-SPRM was used to 




two types of surfaces: a streptavidin surface and a thiol-based SAM surface. The vesicles 
were prepared using two methods: extrusion and sonication. In total, eight different 
conditions for vesicle immobilization were investigated in this study.  
Experimental  
Materials 
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) (Product # 850375) and 1, 2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl) (biotin-DOPE) (Product # 
870282) were purchased from Avanti Polar Lipids Inc. Streptavidin (Product # 21135) 
was purchased from Pierce.  
Preparation of Vesicles 
 Vesicles were prepared from DOPC and mixtures of DOPC with 0.3 mol% biotin-
DOPE. Both lipids were dissolved in chloroform and dried under a stream of nitrogen 
and exposed to vacuum for 4 h. Then PBS buffer (pH 7.4) was added to the dried lipids to 
obtain 1 mM total concentration of lipids. The lipid solution was divided into two 
aliquots to prepare vesicles by sonication and extrusion separately.  
In the sonication method, preparations of DOPC and a mixture of DOPC with 0.3 mol- 
-% biotin-DOPE in PBS buffer were sonicated in a 30 °C water bath for 30 min before 
use. For the extrusion method, both samples were subjected to six freeze-thaw and vortex 
cycles using a dry ice/acetone mixture and a 30 °C water bath. A miniextruder 
(LiposoFast, Avestin) was used to push the lipid solution through polycarbonate 




vesicles was measured by dynamic light scattering (DLS) (NICOMP 380 ZLS, Particle 
Sizing System).  
MFCA- SPRM Analysis of Immobilization of Vesicles 
The SAM surface was prepared as described in Chapter 2 with a mixture of BAT and 
OEG thiols. Four types of vesicle samples (DOPC and biotin-DOPE prepared by 
sonication and extrusion) were flowed through 12 flow cells, with each sample run in 
triplicate.  The flow rate was 50 µL/min and the contact time was about 6 min. Then, 
PBS buffer was flowed through the flow cells after the samples.  
The experiment was repeated using a surface of a streptavidin deposited on the SAM 
surface using the MFCA.  The streptavidin concentration used to pattern the surface was 
100 µg/mL. Immobilization of the streptavidin and vesicles were monitored with SPRM. 
Results and Discussions 
      Analysis of SPR Response to Vesicle Adsorption 
SPR is a label-free, surface-sensitive technique that detects biomolecular adsorption 
via effective local refractive index changes. In Chapter 2, we have demonstrated that the 
SPRM signal (changes in % reflectivity) can be converted to a biomolecule film 
thickness providing quantitative analysis. Figure 6.1 shows the SPR real-time curves for 
adsorption of streptavidin and four types of vesicles. These four types of vesicles are of 
two compositions: DOPC and DOPC with 0.3% biotin-DOPE prepared by sonication or 
extrusion. 
 Figure 6.2 is a comparison of four types of vesicles adsorbed on two surfaces, 




6.2 are summarized in Table 6.1. The signals seem various and random at first. However, 
when the data are compared with reported results also from SPR spectroscopy, it was 
found that the SPR signal was related to the structure of vesicles on the surface. Jung et 
al.
5
 reported that extruded vesicles with biotin bound to a streptavidin surface make a 
planar layer of intact vesicles and this was confirmed with fluorescent dye leakage 
experiment. In their report, the SPR spectroscopy signal of these immobilized intact 
vesicles was 30 nm (shift of wavelength), and the shift for the adsorption of a streptavidin 
layer was 10 nm. The ratio of these two signals was about three. In our experiment under 
the same experimental conditions, the extruded vesicles doped with biotin-labeled lipid 
adsorbed on a streptavidin surface to give a SPR response of 15.51 ± 0.04% reflectivity. 
The SPR response for streptavidin adsorption was 4.96 ± 0.61% reflectivity. The SPR 
signal ratio of intact vesicles to a layer of streptavidin was 3.13, which was close to the 
reported value of three.  Equation 2.1 in Chapter 2 shows that the SPR signal is 
proportional to the thickness of an adsorbed layer. So if the thickness of a streptavidin 
layer is assumed to be close in reported and our experiment results, the thickness of 
vesicle layers will be the same too because of the same signal ratio. Since it is reported 
that the immobilized vesicles were  intact,
5
  the extruded vesicles will also form a layer of 
intact vesicles in our system. 
Sonicated vesicles have been used to created lipid bilayers on a hydrophilic surface;
30
 
so it is assumed that sonicated DOPC vesicles formed a lipid bilayer on SAMs surface. 
The assumption is also reasonable by comparing the SPR signal of the sonicated DOPC 
vesicles (4.74 ± 0.23%) and that of a streptavidin layer (4.96 ± 0.61%). The refractive 






According to Equation 2.5 in Chapter 2, the thickness of a streptavidin layer is 
approximately equal to that of a planar bilayer because the thickness of biomolecule layer 
is proportional to the SPR signal. The reported monolayer of streptavidin has a thickness 
of 5–7 nm, and the thickness of a surface-bound planar bilayer of DOPC is 6.0–7.5 
nm.
16, 31
 The reported thickness of streptavidin and bilayer also confirmed that the 
assumption of DOPC vesicles prepared by sonication form a bilayer structure on a 
hydrophilic SAM surface is reasonable.  
Based on the data analysis and conclusions above, a calculation model was built to 
explain the SPR signal of vesicle adsorption and the corresponding structure on the SPR 
sensor surfaces. The SPR signal is caused by the local effective refractive index change 
of caused by displacement of water (buffer) by the adsorbed lipids. The SPR signal is 
linear to the mass of lipids within the detection region. The total mass of adsorbed DOPC 
can be calculated by multiplying the surface density by the surface area of a bilayer 
assuming the lipid bilayer is an ordered structure with uniform density. Within a fixed 
area (L
2
), if the surface is covered by a planar lipid bilayer as shown in Figure 6.3, the 
surface area of the bilayer is L
2
. If the surface is covered by a monolayer of vesicles with 
a radius of R, the surface area of the lipid bilayer is equal to 4πR2· (L/2R) 2 = πL2. The 
ratio of these two values is π (3.14) and close to that of experimental data (15.51/4.74 = 
3.27). A close packing could make a larger signal ratio. A planar lipid bilayer and a 
monolayer of intact vesicles are two ideal cases of the minimum and maximum coverage 
of lipid bilayer.  
A simple model is shown in Figure 6.4 that explains the transformation from vesicles 
to planar bilayer on supported solid surface.
12




on many factors, such as properties of the surface and vesicles and the interaction 
between adsorbed vesicles. In our measurement, the SPR signals between 4.74 and 15.51% 
reflectivity were compared with the SPR signal of a planar bilayer. The ratios are listed in 
Table 6.1 and can be related the transitional structure in Figure 6.4. For example, double 
bilayers generate a signal twice as large as that of a bilayer, which is equal to a ratio of 
two. The possible structures and effect of physicochemical properties of surface and 
vesicles will be discussed next. Conclusions from SPR experiments can be further 
confirmed with other analytical techniques, such as AFM imaging and QCM 
measurements.
16
   
Effect of Vesicle Size 
The difference between vesicles prepared by sonication and extrusion is the size 
distribution. The sizes of vesicles prepared in our experiments were consistent with 
reported results. With dynamic light scattering measurement, the extruded DOPC vesicles 
were 121.5  ±  10 nm. Published reports of the same lipids and method produced vesicles 
with an average size of 112  ± 6 nm.
26, 29
 The sonicated vesicles were 33.4 ± 2.6 nm and a 
small percentage was 177.2 ± 14.4 nm. For the same DOPC vesicles, the reports also 
included a bimodal size distribution, with a majority of size of 28 ± 2 nm and a small 
percentage of vesicles with a size of 196 ± 10 nm.
26
 
For the DOPC vesicles with biotin, both sonicated and extruded vesicles bound to a 
streptavidin surface and led to relatively high SPR signals of 15.51 ± 0.04 and 14.32 ± 
0.67% reflectivity. These vesicles were intact based on our analysis of the data described 




specific immobilization on the streptavidin surface. For vesicle adsorption on the SAM 
surface (no streptavidin layer), there was a large size effect. The SPR response measured 
for adsorption of the extruded DOPC vesicles (12.40 ± 0.85% reflectivity, ratio of 2.62) 
was nearly twice as large as the response for sonicated vesicles (6.57 ± 0.26% reflectivity, 
ratio of 1.39). The difference in signal can be explained by the fact that small vesicles 
easily break and spread on the surface to form a bilayer fast; while it takes a longer time 
for larger vesicles to adsorb on the surface, become flattened and ruptured into double 
bilayers and finally form a single bilayer. Adsorption of extruded DOPC vesicles 
containing biotin on a streptavidin surface produced a ratio of 2.62, which puts the signal 
between the signal ratio for a double bilayer of two and that for an intact vesicle of 3.14, 
so it is possible that most vesicles are deformed after adsorption on the SAM surface. 
Adsoprtion of the sonicated vesicles produced a ratio of 1.39 and likely had structures of 
mixed single and double bilayers.  
Effect of Surface Hydrophilicity 
The hydrophilicity of the surface is an important factor that determines the interfacial 
force and the consequent form of vesicles on the surface. DOPC vesicles tend to form a 
bilayer on a hydrophilic surface.
30
 DOPC vesicles adsorbed on a streptavidin surface 
show higher signals than those adsorbed on SAMs in the experiments summarized in 
Table 3.1. The mixed binary SAM surface  is composed of OH-  and biotin-terminated 
functional groups and the surface is  hydrophilic as confirmed by the contact angle of 
water droplets of over 100°.
32
 The streptavidin surface has a contact angle of 26.33° and 
is hydrophobic compared to the SAM surface.
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also could affect the formation of bilayers. A hydrophobic surface is preferred for intact 
vesicle immobilization, which correlates with the observations. 
Effect of Vesicle Composition 
It is interesting to note that under all of the tested conditions (vesicles prepared with 
sonication or extrusion, adsorption on SAM or streptavidin surfaces), adsorption of 
vesicles of DOPC with 0.3 mol% biotin-DOPE showed a higher SPR response than 
DOPC vesicles without biotin as shown in Table 6.1. The change of composition of lipids 
could affect the molecular interactions between lipids with the surface, subsequent 
binding energy and the conformation of vesicles on the surfaces. How the biotin-DOPE 
change the vesicle immobilization can be probed by varying the concentration percentage 
of biotin-DOPE in the DOPC vesicles.  
Nonspecific Adsorption of Intact Vesicles 
The SPR responses for DOPC vesicles adsorption on a streptavidin surface when the 
vesicles were prepared by sonication (7.09 ± 0.48% reflectivity) and extrusion (10.26 ± 
0.35% reflectivity) were 1.5 and 2.15 times that of a bilayer on a SAM surface (4.74 ± 
0.23% reflectivity), respectively. The sonicated DOPC vesicles may form a mixture of 
double bilayer and planar bilayer on the surface; the extruded DOPC vesicles may have 
deformed vesicles and planar bilayer according to the calculation model. This 
morphology of DOPC vesicle adsorbed on a streptavidin surface could be further 





The MFCA-SPRM is a label-free, high-throughput technique useful for 
characterization of the adsorption of vesicles. Adsorption of extruded and sonicated 
vesicles on SAMs and streptavidin surfaces was performed with the MFCA-SPRM to 
investigate the effect of vesicle size, lipids composition and hydrophilicity of the surface 
on the vesicle structure upon adsorption on solid surfaces. The results show that vesicles 
prepared by extrusion with specific binding are preferred for immobilization of intact 
vesicles on a hydrophobic protein surface. A calculation model is proposed to correlate 
the MFCA-SPRM signal with vesicle structure on the surface. The accuracy of the model 
could be further investigated with other analytical techniques such as AFM.  
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Figure 6.1. SPR real-time curves of adsorption of streptavidin and four types of vesicles 
immobilized on of streptavidin layers on a planar surface.  The DOPC (DOPC) and 




















































































































Figure 6.2. Comparison of SPR curves of four types of vesicles adsorbed on two different 
surfaces. (a) Streptavidin surface and (b) amixed biotin-terminated thiol SAM surface 












































































































Figure 6.3. A calculation model of the total surface area of vesicles. The model was based 
on the assumption that intact vesicles formed a monolayer of ordered structure on the 






















































































Figure 6.4. A model to interpret the transformation from vesicles to a supported planar 
bilayer on a solid surface as suggested by AFM imaging. The vesicle adsorbs on the 
surface (A-C), becomes flattened from the edges, expands, spreads and collapses to form 
double bilayers (D-F). Then the vesicle either rolls (G) or slides (H) to be single bilayer 
(I). Reprinted from  Biophysical Journal 2000, 79, Jass, J.; Tjarnhage, T.; Puu, G., From 
Liposomes to Supported, Planar Bilayer Structures on Hydrophilic and Hydrophobic 
Surfaces: An Atomic Force Microscopy Study, 3153-3163, Copyright (2000), with 
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Table 6.1. SPR signals of the adsorption of four types of vesicles on SAM and 










































Type of Vesicles SAMs Surface Streptavidin Surface 
 % reflectivity ratio % reflectivity ratio 
Extruded-Biotin 12.40±0.85 2.62 15.51±0.04 3.27 
Extruded-DOPC 9.04±0.26 1.91 10.26±0.35 2.16 
Sonicated-Biotin 6.57±0.26 1.39 14.32±0.67 3.02 
Sonicated-DOPC 4.74±0.23 1.00 7.09±0.48 1.50 
CHAPTER 7 
CONCLUSIONS 
The integrated MFCA-SPRM system incorporates multichannel microfluidics with the 
surface sensitive technique of surface plasmon resonance microscopy.  The MFCA-
SPRM is useful for studying biomolecular binding events, including kinetics, at the 
liquid-solid interface. The multiple-step continuous-flow deposition with the MFCA 
enables in situ protein immobilization and interaction analysis in a microarray format. 
The procedure of integrating the MFCA with a custom-built SPRM was described in 
Chapter 2. Interactions between antibodies were adopted as a model to demonstrate the 
capability of in situ microarray fabrication and analysis with the MFCA-SPRM. 
In Chapter 3, we used both modeling and experimental methods to investigate factors 
that impact the biomolecular interaction analysis based on the MFCA-SPRM. The 2D 
modeling results showed that the reactant concentration in solution and on surface and  
the binding affinity constants are important factors in binding analyses with MFCA-
SPRM. However, there are some limitations of the modeling because mass transport and 
reactions in 3D flow cell are more complex than the 2D modeling. The biotin-streptavidin 
and Daclizumab-IgG interactions were used as two model systems in the experimental 
investigations of effects of flow rate and surface heterogeneity on analyses of 
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biomolecular interactions. The experimental results show the reaction rate in the MFCA 
is proportional to the flow rate. As the flow rate increases, the reaction transit from 
diffusion-limited to reaction-limited. For a diffusion-limited reaction, the surface 
concentration of product changes linearly with time but 1/3 power of flow rate with a 
flow cell of fixed geometry.  The heterogeneous SAMs and protein surface create to 
heterogeneous local refractive changes because the 3D structure of binding sites on 
microscopic scale was not uniformly active and evenly distributed, which was a major 
source of spot-to-spot signal variations in the measurements. The activity of immobilized 
proteins did not increase linearly with their surface concentration. A lower surface 
concentration of binding sites demonstrated higher activity, but higher surface 
concentration of binding sites captured the most absolute amount of analysts. Changing 
the geometry of flow cell could improve the mass transport but the effect is limited as 
shown by initial investigations. Finally, we identified that another major source of signal 
variations among microspots was the shift of the light incident angles from the center to 
edges of the laser beam after the light was refracted by a hemi-spherical prism. Using a 
hemi-spherical prism of a larger diameter could minimize the SPR sensing area or 
changing to prism of other shapes such as dove prisms that can eliminate issues due to the 
angle shift.  
The optimized MFCA-SPRM system was applied in multiple projects of bimolecular 
interaction analysis. A preliminary investigation of developing an immunogenicity assay 
of Daclizumab with MFCA-SPRM was reported in Chapter 4.  Three serum samples of 
multiple sclerosis patients treated with Daclizumab for different durations (0, 4, and 6 
years) were screened with a Daclizumab-coated SPR surface to detect ADAs. The sample 
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from the patient without treatment shows a high response that exceeds the average signal 
of the non-specific adsorption. However, it is difficult to identify the surface bound 
molecules with SPR. MALDI MS has shown to be a fast and accurate technique for 
molecular identification via mass to charge ratio. One solution is to combine the SPR 
with MALDI MS to perform quantitative analysis of protein adsorption on the SPR 
sensing surface and then identify surface bound proteins on the SPR substrate surface 
with MALDI MS. However, due to the thickness limitation of substrates required by a 
commercial MALDI MS system, the combination of MFCA-SPRM with MALDI MS 
was challenging. The preliminary experiments were done using arrays prepared ex situ 
with the MFCA. Chapter 5 presented the result of using MALDI MS to identity proteins 
on microspots of an antibody array created by the MFCA on a gold-coated microscope 
slide. It was found that it was possible to identify the antibodies on the microarray created 
by the MFCA. Further investigation could probe important factors to improve the 
detection limit of MALDI MS. This preliminary work also demonstrated the versatility of 
applying MFCA as a microspotter in MALDI MS sample preparation. 
 Characterization of vesicles adsorption on solid surfaces by MFCA-SPRM was 
reported in Chapter 6. The mobility of vesicles leads to the formation of  bilayers, 
flattened vesicles or intact vesicles at surface. SPR can only detect changes caused by 
refractive index, so it is challenging to determine the structure of vesicles on the surface.  
Compared with reported result of vesicle structure characterized by atomic force 
microscopy and SPR spectroscopy, a calculation model was proposed to correlate SPR 
signals with the structure of the vesicles on the surface. Experiments with AFM to 
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analyze the vesicles structure under tested conditions could further prove the accuracy of 
the model.  
This dissertation has demonstrated the setup of an integrated MFCA-SPRM system, 
the optimization of experimental conditions for microarray analysis of biomolecular 
interactions. The optimized conditions and developed methods can be applied for future 
large-scale sample analysis, such as development of immunogenicity assay and 
characterization of vesicle adsorption. The MFCA-SPRM system is also a versatile tool 
to be combined with other analytical instruments like MALDI MS for application in 
many research fields such as fundamental biomedical research, drug discovery and 
biomarker diagnostics.   
 
 
